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Abstract
Carbohydrate and protein interactions are often essential in viral and bacterial infection,
the immune response, cell differentiation and development, and the progression of tumor
cell metastasis. Therefore, an understanding of carbohydrate–protein interactions at the
molecular level would lead to a better insight into the biological process of living systems
and assist in the development of therapeutic and diagnostic strategies. Our goal was to
synthesize different mannose derivatives, immobilize them on nano-patterned surfaces
and carry out binding studies with mannose-binding lectins in order to characterize
carbohydrate–protein interactions.
Different derivatives of D-mannose (monosaccharide, (1→2)-linked disaccharide,
(1→3)-linked disaccharide, and (1→2, 1→3)-linked trisaccharide) with tethered –SH
groups were synthesized. Alkyne-terminated D-mannose derivatives were synthesized to
be immobilized via click chemistry on azide-functionalized glass slides. These molecules
were constructed by glycosylation of appropriately protected glycosyl donors and
acceptors, followed by free-radical addition to introduce the thiol terminals onto the
aglycons. Subsequent deprotection afforded the corresponding free-OH saccharides.
Standard robotic microarray printing technology was used to couple these thiolterminated aglycons to epoxide-functionalized glass slides.
Using a fluorescence scanner, binding between carbohydrates and Con A were
quantified and processed to obtain dissociation constants (KD). The (1→2)-linked
disaccharide 18 showed highest binding with Con A with dissociation constant of 58 nM
vi

[nano molar]. The (1→3)-linked disaccharide 24 had a dissociation constant of 68 nM
[nano molar] with Con A. The differences in binding constants seem to be greater at
higher concentrations above 400 µM [micro molar]. The monosaccharide 5 had an
average surface dissociation constant of 76 nM [nano molar] and 91 nM [nano molar] for
the trisaccharide 29. In general, the disaccharides 18 and 24 showed enhanced binding
interaction with Con A than the monosaccharide 5 and trisaccharide 29.
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PART ONE
TOTAL SYNTHESIS OF MANNOSE DERIVATIVES
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I.

Introduction

1. Carbohydrates
The major classes of organic compounds common to living systems are lipids, proteins,
nucleic acids, and carbohydrates.1 Carbohydrates are very familiar to us; we call many of
them “sugars”. They make up a substantial portion of the food we eat and provide most
of the energy that keeps the human engine running. Carbohydrates are the structural
components of the walls of plant cells and the wood of trees; they are also major
components of the exoskeletons of insects, crabs and lobsters. Historically, carbohydrates
were once considered to be the hydrates of carbon because their molecular formulas in
many (but not all) cases correspond to Cn(H2O)m. It is more realistic to define a
carbohydrate as a polyhydroxy aldehyde or ketone, a point of view closer to structural
reality and more suggestive of chemical reactivity.2

1.1. Classification of carbohydrates
The Latin word for sugar is saccharum, and the derived term saccharide is the basis of a
system of carbohydrate classification. A monosaccharide is a simple carbohydrate, one
that on attempted hydrolysis is not cleaved to smaller carbohydrates. Glucose (C6H12O6),
for example is a monosaccharide. The other common six-carbon sugars (hexoses) are Dfructose, D-galactose and D-mannose. Monosaccharides rarely exist as open carbon
chains, but more commonly found as cyclic ring structure of five or six atoms. The
simple sugars are the building blocks of carbohydrates. A disaccharide on hydrolysis is
2

cleaved to two monosaccharides that may be the same or different. Sucrose (common
table sugar) is a disaccharide which upon hydrolysis yields one molecule of glucose and
one of fructose. There are two basic types of disaccharides, reducing and non-reducing.
Reducing disaccharides are two monosaccharides linked via the anomeric center of one
glycosyl unit to a hydroxyl group of another sugar, which leave free a hemiacetalic OH
group at the anomeric center. Non-reducing disaccharides are linked at both the anomeric
positions of the two monosaccharides. Sucrose is a non-reducing sugar, since both sugars
are linked through their anomeric carbons.
An oligosaccharide (oligos is a Greek word that in its plural form means few)
yields two or more monosaccharides on hydrolysis. Thus, the IUPAC classifies
disaccharides, trisaccharides, and so on as subcategories of oligosaccharides.
Polysaccharides are high-molecular-weight polymers built by repeated condensations of
monosaccharides. Examples are starches, glycogen, cellulose, and carbohydrate gums.
Recently, the IUPAC has chosen not to specify the number of monosaccharide
components that separates oligosaccharides from polysaccharides.2 This standard is a
more practical one; it notes that an oligosaccharide is homogeneous. Polysaccharides are
almost always mixtures of molecules having similar, but not necessarily the same, chain
length. Cellulose, for example, is a polysaccharide that gives thousands of glucose
molecules on hydrolysis but only a small fraction of the cellulose chains contains exactly
the same number of glucose units. Carbohydrates are found on every cell surface; they
are found both on eukarytic and prokaryotic cell surfaces.
3

2. Eukaryotes and Prokaryotes
The cell is the basic functional unit of life and often called the building block of life.
There are primarily two types of cells: eukaryotic and prokaryotic cells. Like the name
implies, eukaryote mean true nucleus to the extent that, unlike prokaryotes, eukaryotes
have a nucleus. Animals, plants, fungi, and protists are eukaryotes. They are organisms
with complex cell or cells and where the generic material is organized into a membranebound nucleus or nuclei. Animals, plants, and fungi are mostly multicellular, while many
sorts of protists are unicellular.3 Eukaryotic cells also contain membrane-bound
organelles such as mitochondria and choloroplasts. The prokaryote cell is simpler, and
therefore smaller, than a eukaryote cell, lacking a nucleus and most of the other
organelles of eukaryotes. There are two kinds of prokaryotes: bacteria and archaea; they
share a similar structure. Nuclear material of prokaryotic cell consists of a single
chromosome that is in direct contact with the cytoplasm. Prokaryotes contain only a
single loop of stable chromosomal DNA stored in an area called the nucleoid.
Mitochondria and chloroplasts are membrane-bound organelles in eukaryotes responsible
in performing various metabolic processes; however, in prokaryotes similar processes
occur across the cell membrane. The difference between the structure of prokaryotes and
eukaryotes is so great that it is considered to be the most important distinction among the
groups of organisms. The structures of eukaryotic and prokaryotic cells are shown in
Figures 1 and 2, respectively.4
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Figure 1. Eukaryotic cell.

Figure 2. Prokaryotic cell.4
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3. Glycoconjugates
The glycocalyx is a complex layer of glycoconjugates (carbohydrates linked to proteins
and lipids) that forms an outer coat on both eukaryotic and prokaryotic cells (Figure 3).5
For a long time the role of the glycocalix was ascribed to the protection of the cell against
the outside environment by repulsive interactions. However, just this role cannot explain
the complexity of glycoconjugates. Their location at the outer leaflet indicates that
carbohydrates have to be involved in some way in cell-adhesion and recognition
processes based on both interactive and repulsive interactions.6
The complexity of these conjugates has made their study difficult, and they have been
kept aside for many years in comparison with other biomolecules such as nucleic acids or
proteins. This complexity arises mostly due to the diversity in structure of carbohydrates.7

Figure 3. Glycocalyx.
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The chain length of the saccharides can vary widely from monosaccharides up to
branched oligosaccharides with more than 30 building blocks, or in the case of
polysaccharides to several thousand building blocks. The nine common monosaccharides
found in mammalian cells (Figure 4) can be combined in various ways to form structures
more diverse than those accessible with the twenty naturally occurring amino acids or the
four natural nucleotides. A comparison of the permutations of hexamer formation
illustrates this point well. Whereas, DNA (with a basis set of 4) and amino acids (with a
basis set of 20) may construct a biological language for information transfer of 4096 and
6.4 × 107 ‘words’, respectively, carbohydrates have access to greater than 1.05 × 1012
variations.8

OH

OH
O

HO
HO

OH
OH

HO
HO

OH OH

OH
O

O

OH
D-Mannose (Man)
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OH OH

OH
O

HO

OH
NHAc
N-Acetylgalactosamine (GalNAc)
HO

HO OH
HOOC
HO
HO

O
OH
OH
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Figure 4. The nine common monosaccharides found in mammalian cells.
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Added to this is the variety afforded by anomeric stereochemistry, ring size and
sub-unit modification (e.g., sulfation, phosphorylation or acylation), and it can be quickly
seen that this greater variety of possible combinations gives the language of
carbohydrates exquisite eloquence.8 This language has been christened ‘glycocode’—a
term that well represents the potential level of complex information that carbohydrate
structures are able to convey. The vast number of potential permutations represents a
technological barrier and means that no longer can oligosaccharidic structures be made
on an iterative basis since there are far too many possible synthetic targets. It is therefore
crucial that the design of new carbohydrate-containing structures be guided by the
identification of the associated functions of existing structures.
Cells, bacteria, toxins and other organisms interact with their receptors, which in
most cases are glycoconjugates (glycolipids and/or glycoproteins), at the cell surface.
Three models for glycoconjugate interactions have been suggested: (i) Carbohydrate
Recognition Model—only single oligosaccharide motifs are ligands; (ii) Cluster Model—
clusters of many carbohydrate motifs are ligands; (iii) Carbohydrate–Protein
Recognition—the binding ligand is both the carbohydrate motif and a given region of
protein that supports it.8
Since most glycans are on the outer surface of cellular and secreted
macromolecules, they are in a position to modulate or mediate a wide variety of events.
These interactions mediate cell adhesion, cell motility, and cell–cell communication and
recognition of toxins (Figure 5). They are also in position to mediate interactions between
8

organisms, for example between host and parasite. Examples of important cell-surface
recognition events include: (1) cell–cell adhesion in inflammatory processes involving
lectin–carbohydrate interactions, which mediate leukocyte latching to inflamed tissues;9
(2) neutrophil penetration is thought to be mediated by CD177, a glycoprotein;10 (3) HIV
infection is mediated by glycoprotein (GP 120) binding with cell-surface receptors;11 and
(4) the metastasis of certain cancers involves saccharide-mediated events.12 Most
recently, the precise binding of human sperm cells to the ovum has been defined as a
protein–carbohydrate interaction.13

Figure 5. Cell–cell interactions, cell–matrix adhesion, cell–viral recognition
and adhesion, and cell–bacterial adhesion.

9

In addition, many important biological interactions and functions mediated by
glycans are potentially amenable to manipulation in vivo. For this reason alone,
glycobiology and carbohydrate chemistry have become of increasing importance in
modern biotechnology. Furthermore, several human diseases are characterized by
changes in glycan biosynthesis that can be of diagnostic and/or therapeutic significance.

4. Carbohydrate–Protein Interactions
Among the interactions involving carbohydrates, one of the most important is the binding
between carbohydrates and proteins. Proteins excluding enzymes and immunoglobulins
that bind carbohydrates are generally called lectins.14 Simply put, lectins are proteins that
bind carbohydrates.15 They are decipherers of the glycocode, and despite their very
shallow binding sites, show a remarkable specificity in their binding of multivalent
complex carbohydrate structures.16 The term lectin, which owes its origin to the Latin
word legere meaning specific, was first used by Boyd in 195417 to describe proteins that
show a potent and highly specific ability to bind glycosylated structures. However, they
were first discovered in plants more than 100 years ago, and they are now known to be
present throughout nature. The concept of glycans being specifically recognized by
proteins dates back to Emil Fischer, who used the phrase “lock and key” (Figure 6) to
refer to enzymes that recognize specific glycan substrates.18,19
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Figure 6. Lock and key mechanism
The characterization of specific interactions between sugars and proteins in threedimensional space was realized by the determination of the crystal structure of lysozyme,
which was the first “carbohydrate-binding protein” to be crystallized. Its structure was
solved in a complex with a tetrasaccharide in an elegant series of studies by Phillips and
co-workers in the late 1960s.
Lysozyme is an ellipsoidal protein that has a long cleft that runs for most of the
length on one surface of the protein (Figure 7).18 This cleft is astonishingly large,
considering that lysozyme has only 129 amino acids, and is capable of accommodating a
hexasaccharide and cleaving it into a disaccharide product and a tetrasaccharide product.

11

Figure 7. Lysozyme binding glycans18

Other glycan-binding proteins whose three-dimensional structures are of historical
significance are concanavalin A (crystal structure reported in 1972) and influenza virus
hemagglutinin (crystal structure reported in 1981). In addition, critical information to the
development of this field was gathered by Lemieux and Kabat and co-workers in studies
on the combining sites of lectins and antibodies toward specific blood-group antigens.18
Currently, many lectins have been isolated, characterized and classified into different
groups.

12

4.1. Types of lectins
Lectins are cell agglutinating proteins of non-immune origin that are widely distributed in
nature, being found in plants, microorganisms and animals.20 Aside from this common
trait, they differ greatly in structure, organization, and biological purpose. As more and
more lectins are discovered and studied, a consistent classification of lectins has been
developed based on amino acid sequence motifs in the carbohydrate-recognition domains
(CRD) of two groups of lectins: one group requires calcium for recognition and is
therefore called C-type lectins, and the other group requires “free” thiols for stability and
is termed S-type lectins. Meanwhile, lectins of these two groups that recognize mannose6-phosphate are found distinct from all others, thus justifying their recognition as P-type
lectins.21
C-type lectins are also distinguished from other lectins by a unique protein fold.22
Two particular important features of C-type lectins that make them appealing for many
studies are: a. Hierarchical pattern recognition. C-type lectins share the lectin hallmark
of multimeric architecture. The prototypical ligand preferences of individual C-type
lectin domains (CLDs) are typically for mannose (Man) (most vertebrate lectins) or
galactose (Gal) (invertebrate lectins). Affinity for simple, free sugars (monosaccharides)
is demonstrable but weak. Strong interactions (avidity) result from simultaneous binding
to multiple ligands (multivalency). Because of the intermediacy of the calcium ions, Ctype lectins make few direct protein–carbohydrate contacts, and binding occurs primarily
through ligation of the calcium ion by the equatorial 3- and 4-hydroxyl groups on the
13

sugar (Figure 8).

Because the protein and sugar are insulated by the calcium ion,

recognition is somewhat loose and primarily involves a single sugar unit. Sugars can be
recognized in alternative orientations, and structurally related sugars can be recognized
(e.g., N-acetylglucosamine instead of mannose).

Thus, how strongly a particular

biological surface is recognized depends heavily on presentation.

Figure 8. Some sugar motifs recognized by C-type lectins.

b. Highly diverse organization. Any protein containing at least one C-type lectin domain
(CLD) is classified as a C-type lectin.22 This large group includes single-CLD, soluble
proteins, and integral membrane proteins containing extracellular CLDs, and multidomain proteins containing one or more CLDs. The organization of mannose-binding
lectin (MBL) is shown in Figure 9. MBL assembles into a bouquet-shaped 18-mer (6 ×
3).23 Others adopt a variety of scaffolds for their presentation.
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Figure 9. Architecture of soluble collectins, a group of mannose-binding
lectins involved in innate immunity, showing hierarchical organization. (Illustration
adapted from van de Wetering et al.24)

The endocytic pathway involves lectin recognition of ligands at the cell surface,
internalization via coated pits, and delivery of the complex to endosomal compartments
where the low pH induces dissociation of ligand and lectin. The lectin recycles to the cell
surface and repeats the process.25 The selectins are a class of type I membrane-bound Ctype lectins expressed in the vascular endothelium and on circulating leukocytes. At this
time, there are only three selectins that have been indentified: L-selectin, expressed on all
leukocytes; E-selectin, expressed by cytokine-activated endothelial cells; and P-selectin,
expressed constitutively in granules of platelets or cells.

4.2. Multivalency in carbohydrate–protein interactions
It is frequently found that interactions between monovalent carbohydrate ligands and a
single binding site (CRD) of a complementary receptor protein are weak with
dissociation constants in the millimolar range.26

Nature effects tight binding by

multivalency which has been recognized as an important functional principle in
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carbohydrate–protein interactions during recent years.27,28 Multivalent interactions
provide the basis for mechanisms of both agonizing and antagonizing biological
interactions that are fundamentally different from those available in monovalent systems.
Additionally, the order of ligand specificities in monovalent interactions has been found
to be greatly magnified in a multivalent presentation.28 Multivalency in carbohydrate
recognition is easily achieved, as the involved ligands are most frequently presented as
multiple copies of recognition elements, and this usually finds an analogy in a cluster of
receptor binding sites.
Enhancement of affinity upon multivalent binding requires that the change in
Gibbs free energy ∆G upon binding of an N-valent ligand is greater than N times the
change in Gibbs free energy upon binding of each of the constituent monomeric ligands
to an individual lectin binding site.20 In other words, multivalent effect is only observed
when a higher binding energy is found in multivalent binding than it can be expected of
the sum of individual binding energies. Multivalent interactions have several advantages
and controls a wide variety of cellular processes including cell surface recognition events,
the immune response, tumor metastasis, fertilization, and microbial adhesion. An
understanding of the mechanistic principles that underlie multivalent binding events
would facilitate the generation of new classes of carbohydrate-based therapeutic agents
because the low affinity of saccharide ligands for their lectin receptors is, of course, one
major impediment for the development of carbohydrate derivatives as therapeutics.

16

The first synthetic oligovalent glycoligands that showed enhanced affinities were
introduced by Y.C. Lee and co-workers.14, 29,30 With these simple cluster glycosides, a
logarithimic increase in affinity for multimeric hepatic lectins was observed in a
hemagglutination assay upon a linear increase of scaffolded carbohydrate ligands that
were varied from one to three (Figure 10).31

Figure 10. Structure of cluster glycosides with which the ‘cluster effect’ was
first observed.
For this observation the term ‘cluster effect’ was coined. Currently, Y.C. Lee’s
finding, together with a number of additional exciting observations, made in the context
of multivalency, are a major incentive for the design and preparation of synthetic
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multivalent ligands to serve for the exploration and modification of cell-surface
interactions.32
One important example of functional multivalency in biology is microbial
infection, which requires an adhesion event as a prerequisite. Often microbial adhesion is
mediated by multiple carbohydrate-protein interactions. Blocking of these initiating
interactions may lead to an anti-adhesion therapy against microbial infections based on
carbohydrates, a concept which was first suggested by Sharon et al.32 The best
investigated microbial adhesion system is the adhesion of the influenza virus to its host
cells. In the first step of infection, the influenza virus attaches to the surface of a
bronchial epithelial cell (Figure 11).

Figure 11. Influenza virus attaching to cell surface
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This virus recognizes specific saccharides on the host’s epithelial cells and
utilizes these cellular glycans as receptors to initiate an infection.1 The attachment occurs
by interactions between multiple trimers of the hemagglutinin (HA, a lectin that is
densely packed on the surface of the virus, about 2–4 per 100 nm2) and multiple moieties
of sialic acid (SA, the terminal sugar on many glycoproteins and one that is also arranged
densely on the surface of the target cell, about 50–200 per 100 nm2). HA variants adapted
to humans recognize α-(2→6) linkage whereas strains specific for birds recognize α(2→3) linkage. Recent glycan array analysis in conjunction with mutation studies have
shown that specific mutations control the specificity of a given HA that selectively binds
to a given linkage. These studies helped in understanding and predicting how pathogenic
strains can become virulent towards humans.33,34,35

5. Concanavalin A
In the past few decades concanavalin A (Con A) has become the most widely known and
intensively investigated phytohemagglutinin. Much of this interest stems from the
discovery that this lectin possesses several remarkable biological properties. In addition
to its role as a hemagglutinin,36 a structural probe, and a mitogen,37 Con A has been
shown to restore normal growth patterns to transformed fibroblasts, to serve as an anticarcinogenic agent,38 and to distinguish between malignant and normal cells.39 It all
started in 1919 when James B. Sumner at Cornell University, well known for being the
first to crystallize an enzyme, urease (for which he was awarded a Nobel Prize 21 years
later), isolated from jack bean (Canavalia enformis) a crystalline protein that he named
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concanavalin A. In 1936, Sumner and Howell determined that the crystals of Con A were
isoelctric at pH 5.5.36 Concanavalin A is a metalloprotein composed of subunits with a
molecular weight of 27,000 daltons; each subunit possesses one sugar-binding site. At pH
5.5 and below, the protein exists as a dimer, molecular weight 54,000 daltons. Above pH
5.5 the protein dimers begin to aggregate, forming a tetramer with four binding sites,
each capable of interacting with specific, terminal glycosyl residues of polysaccharide or
glycoprotein chain ends (Figure 12).40

Figure 12. Tetrameric structure of Con A showing 4 binding sites.

Various mammalian cells bind from 106 to 107 Con A molecules per cell,
presumably via surface glycoprotein receptors. This binding can be inhibited by α-D20

mannopyranosides and α-D-glucopyranosides.40 In 1969, Goldstein and co-workers
suggested that unmodified hydroxyl groups at the C-3, C-4, and C-6 positions of the Dglucopyranose (or D-mannopyranose) ring are essential for binding to the active sites of
the protein. They found that the hydroxyl group at C-2 was not essential, but the Dmanno configuration was bound more firmly than the D-gluco configuration. It was
realized that the α-glycopyranosides of these sugars were much more active than the free
sugars, whereas the corresponding β-glucosides were poor inhibitors. These results
suggest that the interaction of Con A with polysaccharides involves the chain ends rather
than intact inner branches.41
In 1972, Edelman and coworkers determined the three-dimensional structure of
Con A with saccharide-binding pocket of approximately 6Å × 7.5Å × 18Å and that the
metal binding sites were at least 20Å removed from the position at which saccharides are
bound.40 Di-, tri- and tetra-saccharides containing D-(1→2)-mannosidic linkages have
been found to bind much more strongly to Con A than their corresponding
monosaccharides.20 The Con A carbohydrate binding site is quite clearly different from
that found in lysozyme, which is a long cleft in the molecule containing up to six subsites
for hexapyranose residues.42 The site in Con A is much smaller, perhaps only involving
one sugar residue and is not a “groove” but only a shallow indentation in the surface
where the pyranose ring lies parallel or almost parallel to the protein surface.43
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II. Statement of the Problem
1. Objectives
Despite the centrality of cell-surface carbohydrates in biological recognition, the
mechanisms by which they are recognized remain poorly understood. An impediment to
progress is the complex structure of the glycocalyx, which makes both chemical synthesis
of the oligosaccharide structures involved and biochemical analysis of their interactions
with recognition proteins highly challenging. Fortunately, advances in both carbohydrate
synthesis44 and nanoscale synthesis and characterization45 have opened the possibility of
emulating a critical subset of glycocalyx features in a context where they can be probed
to elicit quantitative details on protein–carbohydrate recognition.

In this project, a

modular approach to creating carbohydrate structures will be implemented. This
approach will be combined with nanoscale patterning to investigate the influence of
spatial organization and site-specific ligand modifications on the recognition and binding
of carbohydrates by proteins. This dissertation will focus on the developments,
challenges and solutions in the following areas:
A. Synthesis of a collection of chemically defined, diversely presented carbohydrate
monomers and multimers (ligand clusters). The compounds produced will be
novel chemical entities that mimic features of cell surfaces in recognition by
proteins (lectins) and binding to entities such as other cells, toxins (peptides or
small proteins), and pathogens. The structural entities will be readily adaptable to
the study of a number of lectins that have a diverse set of structures and functions.
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Initial studies will be carried out on mannose-binding lectin (MBL), a key protein
in mammals associated with the recognition of fungi and yeasts.
B. Refinement of techniques for the mapping and quantitative assessment of
carbohydrate recognition on synthetic surfaces.

The techniques, using

microarray analysis and fluorescent-tagged lectins will allow direct quantitation
of recognition events and produce correlations between avidity, binding energies,
and ligand organization. These proposed studies will add new dimensions to our
understanding of the effects of valency and density of carbohydrate ligands in
protein–carbohydrate binding.

2. Research Design
The multivalency of carbohydrate interactions is well-known, and several groups have
pioneered the synthesis of compounds displaying multiple carbohydrate ligands,46
primarily with the intent of blocking recognition events at cell surfaces. Parallel work
has focused on the immobilization of carbohydrate ligands on solid supports, including
nanoparticles and carbohydrate microarray surfaces. Interrogation of these surfaces has
been carried out using both fluorescence and atomic force microscopies. Following some
early work in which sugars were attached to the surface of gold,47 Kataoka and coworkers,48 in 2001 reported a lactose–lectin binding study with gold nanoparticles. Since
that time, a number of papers have reported sugars (mono-, di- and more complex
saccharides) incorporated onto the surfaces of nanostructures and related polymeric
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substances, along with characterization and binding studies with a number of proteins.
Laboratories involved include those of Barchi (gold nanoshells, cancer therapeutics),49
Cloninger (dendrimers, probes for carbohydrate–protein interactions),50 Coullierez and
Seeberger (polymers, biological probes),51 Gervay-Hague (gold particles, viral
adhesion),52 Haines and Field (gold nanoparticles, bioassays and detection),53 Kamerling
and Vliegenthart (gold surfaces, pathogen (cell) recognition),54 Mrksich (self-assembled
monolayers, microarrays, on-chip synthesis),55 Penadés (metal oxides, magnetic devices,
biomedical applications),56 Russell (toxin detection),57 Turnbull (amide-linked arrays,
SPR analysis),58 and Wong (microarray analysis)59. These works cited are representative,
not exhaustive.
This project is designed to combine the advantages of clustered ligand
polyvalency, with the development of combinatorial synthesis and surface analysis
techniques, including fluorescence.60 Features that distinguish our proposed work include
(a) controlled ligand presentation via specification of cluster valency and surface density,
and (b) rapid quantitative assessment of recognition events using fluorescence. These
features will provide insight into the aspects of synthetic design that have the most
significant impact on carbohydrate–lectin recognition.
Previous efforts to develop carbohydrate arrays have largely focused on arraying
small spots of pure oligosaccharides on glass surfaces.61 In these designs, the creation
and testing of individual carbohydrate ligands in a parallel manner is emphasized.
Contrarily, our approach emphasizes the integration of spatial and chemical patterning.
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The presentation of carbohydrates is a critical feature of cell recognition and is not fully
addressed by approaches used to date.
A major difficulty in the construction of conventional arrays is the synthesis of a
large collection of pure oligosaccharides. The synthesis of complex oligosaccharides is
notoriously difficult. By emphasizing the presentation aspect of recognition, we will
acquire more information from each carbohydrate derivative than is currently possible.
Combinatorial synthesis is an efficient means of making large numbers of compounds
simultaneously from different combinations of modular building blocks. It has been used
in the synthesis of oligosaccharides intended for immobilization on surface arrays,51 and
recently oligosaccharide synthesis has been carried out on the surface of biochips.55c
Therefore, the first part of this project will involve synthesis of carbohydrate
ligands. We set out to synthesize mono-, (1→2)-linked di-, (1→3)-linked di-, and (1→2,
1→3)-linked tri-saccharides of thiol-terminated mannose derivatives that will be
immobilized on epoxide-functionalized glass slides via covalent bonds. Also, another set
of mono-, (1→2)-linked di- and (1→2, 1→3)-tri-saccharides of alkyne-terminated
mannose derivatives will be synthesized for immobilization via click chemistry unto
azide-functionalized glass slides. These targets have features of glycans that are the most
abundant on the glycocalyx and serve as ligands for most receptors.
Screening of carbohydrate arrays has traditionally been accomplished by
interrogating them with fluorescently labeled proteins and measuring the fluorescence
intensity localized at each spot.55b This approach provides useful information regarding
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relative affinities and distinctive patterns of recognition that are useful for characterizing
and subsequently identifying proteins.

Our array platform seeks to maintain the

advantages of fluorescence interrogation regarding overall binding strength and the
number and nature of carbohydrate ligands associated with each interaction. Therefore,
the second part of the project will involve a preliminary microarray analysis of binding
interactions between thiol-terminated mannose derivatives with Con A.

3. Retrosynthetic Analysis
3.1. Retrosynthetic analysis of thiol-terminated mannose derivatives
There are so many variables involved in the synthesis of oligosaccharide that each target
compound requires that a particular strategy be developed. The strategy must take into
consideration the monomers to be bonded, the types of inter-unit linkages to be made and
the sequence in both the topological and chronological senses in which they must be
linked.
Our plan is to install a thiol-functionalized spacer-arm into the reducing end of a
mannose-bearing saccharide. The synthesis of mannose-bearing oligosaccharides is well
documented in the Schmidt glycosylation that makes use of glycosyl trichloroacetimidate
donors.62 In the Schmidt glycosylation, a trichloroacetimidate donor, prepared from a
well-protected 1-OH-free unit can be used to glycosylate another sugar with a free OH
group (acceptor). In this project, we are going to use protected D-mannosyl
trichloroacetimidate to react with protected 2-OH-free or 3-OH-free D-mannose acceptors
in order to establish glycosidic connections.
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Normally, all hydroxyl groups of the acceptor other than that to be glycosylated
must be protected. The hydroxyl groups can be protected as ethers, esters, or acetals.
Carbohydrates can be easily condensed through their hydroxyl groups with a variety of
both organic and inorganic acid derivatives to give esters. Carbohydrate acetates have
been encountered in monomeric and polymeric natural materials, but they are known as
synthetic products which often show favorable crystalline properties, and from which the
parent alcoholic compounds can be recovered under basic or acidic conditions.
Deacetylation can be effected by the well documented and convenient Zemplén
procedure,63 in which NaOMe (0.025 M) is employed in catalytic amounts in methanolic
solution. Use of acetyl protecting group in this synthesis is appealing not only because of
the ease to protect/deprotect but more importantly, its neighboring-group participation
effect that will ensure α-anomeric selectivity of the glycosidic bond. Neighboring group
participation (as shown in Scheme 1) occurs when a molecule that can undergo
nucleophilic substitution also contains a substituent that can act as a nucleophile.64
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Scheme 1. Neighboring-group participation.
As a result, the rate and stereochemistry of the nucleophilic substitution are
strongly affected. Since our desired stereochemistry is the α-linkage, the acetyl protective
group will work in our favor. Now that the construction of oligosaccharide can be carried
out by the Schmidt glycosylation, our attention will be drawn to the installation of thiol
functionalized spacer-arm to the reducing end of the trisaccharide.
Currently in the literature, there are four major ways to introduce a thiol group
into a sugar unit. In 1997, Vliegenthart, Kamerling, and co-workers reported an improved
method to introduce thiol functionality: thiol addition to protected allyl glycosides via a
radical addition pathway as shown in Scheme 2.65 The radicals initiated by
azobisisobutyronitrile (AIBN) were able to activate a dithiol, and subsequently the
activated dithiol reacted with various allyl glycosides in 1,4-dioxane at 75 oC to yield
thiol spacer-armed glycosides.
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Scheme 2. Vliegenthart’s method for thiol addition.
The second way to install the thiol spacer-arm was developed in 2003 by Penadés
and co-workers. Again, Schmidt glycosylation is used to put together the saccharide units
with an SH-protected alcohol as shown in Scheme 3.66 While the Schmidt glycosylation
can be carried out smoothly without any issues, our project itself doesn’t need such a long
spacer-arm as 11 carbons. Since we intend to use various linkers and adaptors to link
different molecules to the nano-surface, the length of the carbohydrate spacer-arm must
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be kept within a certain range: an arm of 11 carbons is more suitable to be attached to the
surface without use of any other linkers.

Scheme 3. Penadés’ method for thiol addition.
The third approach, as reported by Kamerling and co-workers in 2005, took
advantage of reductive amination to introduce the thiol functionality. They used a tritylprotected cysteamine (2-aminoethanethiol) to do reductive amination in presence of
NaCNBH3 in DMSO as shown in Scheme 4.67

Reductive amination is a well-

documented and robust chemical method widely used in various situations. There should
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be no problem to apply this method to our syntheses. Since a number of oligosaccharide
structures were evaluated in this paper, this would be considered an alternative approach
to introduce a thiol terminus if the thiol addition method failed. The major drawback to
this process is that reductive amination opens the reducing-end terminus to form an
alditol derivative.

Scheme 4. Kamerling’s method to introduce cysteamine into a free-hydroxy
glycan.
The fourth major way for installation of thiol terminal is the photoaddition of a
dithiol to a terminal allyl group. An example of this methodology was reported in 2004
by Kamerling, Vliegenthart and co-workers. In this paper, the authors added 1,6hexanedithiol photochemically to the double bond of an allyl group in MeOH under the
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radiation of a UV light as shown in Scheme 5.68 However, there were two drawbacks that
make this approach not applicable in our project: (1) the length of spacer-arm obtained
here was also longer than what we expected; (2) photochemistry is not in general a good
way for large-scale synthesis in that it produces insoluble precipitates during UV
radiation, and therefore, this method should be avoided if other approaches are possible.

Scheme 5. Kamerling’s second method to introduce sulfide into a freehydroxy glycan.

In conclusion, we will adopt Vliegenthart’s thiol addition method (Scheme 2) to
add a dithiol by means of a free-radical reaction to the allyl group of our mannose32

bearing trisaccharide, since it is the most convenient and straightforward method to
consider. Also, this method was successfully used in our research group by Chao Wang
resulting in a high yield of 85%.69 The proposed approach to synthesize a thiolterminated mannose-bearing trisaccharide is shown in Scheme 6.
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Scheme 6. Proposed synthesis of a trisaccharide.
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SH

The same approach will be used for the synthesis of the thiol-terminated (1→2)-linked,
(1→3)-linked disaccharides and also for the synthesis of the thiol-terminated
monosaccharide.

3.2. Retrosynthetic analysis of alkyne-terminated mannose derivatives
Since we desired to evaluate the synthetic oligosaccharides for their biological activities
on solid surfaces, the choice of the reducing end aglycon was very important. For our
second set of sugars, we chose the propargyl glycoside since it is suitable for
cycloaddition reaction with azide-functionalized surfaces.70,71

Due to the ease of

installing and uninstalling propargyl-terminated aglycons to oligosaccharides, propargyl
glycosides can be synthesized in two major ways. A stepwise approach in which one
monosaccharide unit is added to the growing chain or a convergent block synthetic route
can be used. In the stepwise method, it will eventually become necessary to perform
protecting group manipulations on large molecules, which results in low-yielding
reactions. One of the advantages of a convergent block synthesis is that these
manipulations are kept to a minimum since they are instead performed on smaller
fragments.
For the synthesis of the target alkyne-derivatized trisaccharide, a 2 + 1
disconnection was planned. The 3-OH free disaccharide will serve as the acceptor and
could be coupled to the trichloroacetimidate donor following Schmidt glycosylation
procedure (Scheme 7).62 The disaccharide could be obtained from a similar glycosylation
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with a trichloroacetimidate donor and propargyl glycoside acceptor with a 2-OH free
position.

Scheme 7. Retrosynthetic analysis for an alkyne-terminated trisaccharide.
A similar approach will be used for the synthesis of the (1→2)-linked
disaccharide and the monosaccharide. In conclusion, we will adopt the Schmidt
glycosylation between the trichloroacetimidate donor and the propargyl glycoside
acceptor with TMSOTf as catalyst. Conventional Zemplén deacetylation will be applied
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to remove acetyl groups, thus furnishing the alkyne-derivatized mannose derivatives. The
proposed approach is as shown in Scheme 8.

Scheme 8. Proposed synthesis for a propargyl-terminated trisaccharide.

3.3. Retrosynthetic analysis of dimeric mannose derivative
Characterization of glycan clusters on cell surfaces requires detection methods of
domains with high carbohydrate density.72 Recently, there has been great interest in the
development of molecules that are efficient in carbohydrate recognition due to their
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utility as research tools, especially in biomedical applications. As a result, many different
approaches are being pursued for the design of carbohydrate sensors; the most promising
being the use of boronic acids. The Best research group of Department of Chemistry at
the University of Tennessee is one of such groups involved in the synthesis of boronic
acids for the detection of carbohydrate clusters.72,73 Their strategy for detection of
carbohydrate clustering employs carbohydrate-binding boronic acid receptors derivatized
with FRET (Förster resonance energy transfer) pairs (Figure 13). FRET-tagged receptors
upon binding will result in an increase in acceptor emission resulting from energy
transfer.74,74b

h

FRET
Detection

FRET donor-tagged
carbohydrate receptor
Sparse
Glycosylation

Dense
Glycosylation

FRET acceptor-tagged
carbohydrate receptor

Sparse
Glycosylation

Dense
Glycosylation

Figure 13. Diagrammatic representation of boronic acid FRET pairs
employed for carbohydrate recognition.
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Domains of sparse glycosylation should yield little background acceptor emission.
Hence, regions of heavy glycosylation are expected to be identified with high resolution
by employing this FRET-based detection assay. Boronic acids covalently react with 1,2or 1,3-diols to form stable and reversible five- or six- membered cyclic boronate esters, as
shown in Scheme 9.

Scheme 9. The binding process between phenylboronic acid and a diol.
For the development of detection methods using boronic acids, a simple
carbohydrate cluster was to be synthesized. The synthesis of a dimeric mannose
derivative linked by dithylene glycol at their anomeric carbons was designed. The
dimeric mannose derivative could be synthesized from a one-pot glycosylation of
trichloroacetimidate donor and diethylene glycol as acceptor (Scheme 10). Deacetylation
under standard Zemplén conditions will then yield the desired disaccharide.
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Scheme 10. Retrosynthesis of dimeric mannose derivative.
In conclusion, the proposed synthesis of the dimeric mannose derivative will be
carried out by a one pot glycosylation of trichloroacetimidate donor and diethylene glycol
serving as acceptor (Scheme 11).

Scheme 11. Proposed synthesis for dimeric mannose derivative.
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4. Significance
The chemistry described in this dissertation is novel and is the newest frontier at the
interface of chemistry and biology. The synthesized disaccharides and trisaccharides are
all new compounds. Compared to the synthesis of disaccharides, synthesis of
trisaccharides seems to be more challenging due to steric hindrance of groups already
present on disaccharide. Not many other examples of synthesis for thiol-terminated
mannose derivatives exist in literature. The synthesis of propargyl functionalized
mannose disaccharide and trisaccharide is new and refreshing and will make a great
contribution to the new science of click chemistry.
These studies will offer insight into the important question of how cells interact
with proteins and other chemicals in their environment, offering a rich, boundless area of
research for different scientists. The insights gained will find applications in a wealth of
diverse activities ranging from pathogen recognition in animals to biomineralization in
barnacles. More importantly, the techniques developed will have broad implications for
the construction of analytical platforms that display the complex arrangements of
chemical epitopes commonly found in natural systems.
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III. Results and Discussion
1. Synthesis of Thiol-Terminated Carbohydrates
1.1. Synthesis of thiol-terminated monosaccharide 5
The thiol-terminated monosaccharide 5 had been previously synthesized by Brian
Sanders and was used by Medhanit Bahta for preliminary binding studies with mannosebinding lectins.75 A similar approach was used in this synthesis.
Since mannopyranose pentacetate is rather expensive and the pure anomers were
not required, our synthesis commenced with the more affordable mixture of α- and β-Dmannose (1). The target thiol-terminated mannose derivative 5 was prepared in four steps
from commercially available D-mannose (1) as illustrated in Scheme 12. Reaction of Dmannose (1) with acetic anhydride (AC2O) and sodium acetate (NaOAc) at 90 ºC gave a
90.1% yield of pentaacetate 2 with 65% α anomer and 35% β anomer. These anomers
were assigned based on J1,2 coupling constants. The α anomer had J1,2 = 1.6 Hz while the
β anomer had J1,2 = 3.5 Hz. The treatment of penta-O-acetyl-D-mannopyranose (2) with
freshly distilled allyl alcohol under catalysis with boron trifluoride diethyl ether complex
(Lewis acid) produced allyl tetra-O-acetyl-α-D-mannopyranose (3) in 66% yield76.
Following the Vliegenthart’s procedure,65 the monosaccharide 3 was treated with 1,2dithiol in 1,4-dioxane, after free-radical initiation by AIBN and three hours of heating.
The target thiol-terminated monosaccharide 4 was isolated in 61% yield.
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Scheme 12. Synthesis of thiol-terminated monosaccharide 5.
Since the 1,2-dithiol is volatile and carries very unpleasant odors, this reaction was
conducted with traps for 1,2-ethanedithiol. Clorox® bleach solution was used to quench
the smell immediately after the use of syringes and gloves to handle it. Finally, global
deprotection using methanolic sodium methoxide (Zemplén conditions)63 and purification
using LH-20 gave the free thiol-terminated mannose-bearing monosaccharide 5 in 84%
yield.
1.2. Synthesis of acceptor 8
The acceptor 8 required for glycosylation reaction was prepared by the following
4-step procedure starting from previously synthesized allylated monosaccharide 3 as
shown in Scheme 13. Deacetylation of compound 3 under Zemplén conditions gave the
allyl α-D-mannopyranoside (4) with a yield of 81.7%. The product was used without
further purification. Selective protection of the 4,6-diol was achieved upon treatment of
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allyl α-D-mannopyranoside (4) with benzaldehyde dimtheyl acetal under catalysis with ptoluenesulfonic acid, which gave compound 7 in 84% yield.77 Selective protection of 3OH (equatorial) over 2-OH (axial) was achieved with the use of dibutyltin oxide
(Bu2SnO) in the first step of the reaction.78 A suspension of the acetal, allyl 4,6-Obenzylidene-α-D-mannopyranoside (7) and Bu2SnO in toluene was refluxed for 3 h under
an N2 atmosphere to form a stannane intermediate. A Dean–Stark trap was used for
removal of H2O to improve the yield of the reaction. Tetrabutyl ammonium bromide
(Bu4NBr), cesium fluoride (CsF) and p-methoxybenzyl chloride (PMBCl) was added to
the stannane intermediate to afford the desired acceptor (8) in 76% yield.79

Scheme 13. Synthesis of acceptor 8.
The regioselectivity of the p-methoxybenzyl group at the 3-O-position was further
confirmed by adding protective groups on the 2-OH position and observing their
electronic effects on the chemical shift of H-2. Acetylation of the free 2-OH gave the
fully protected allyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside
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(9) as shown in Scheme 14. The acetyl group is an electron-withdrawing group and
caused the NMR signal of H-2 to move downfield from δ 4.11 to δ 4.91 ppm. The 1H
NMR signal of H-3 was not affected.

Scheme 14. Acetylation of allyl acceptor 8.
Following the procedure in Chao Wang’s dissertation,69 the acceptor was reacted
with NaH and BnBr to give the benzylated product 10 (Scheme 15). The benzyl group is
an electron donating group and caused the NMR signal of H-2 to shift upfield from δ 4.11
to δ 3.50.

Scheme 15. Benzylation of allyl acceptor 8.
This careful analysis of the 1H NMR spectrum confirmed that the 2-O-position
was free and could be used for glycosylation to make the (1→2)-linked disaccharide.
With the acceptor in hand, it was now time to synthesize the trichloroacetimidate donor.
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1.3. Synthesis of trichloroacetimidate donor 12
According to Schmidt and co-workers,62 glycosyl trichloroacetimidates are such powerful
glycosyl donors that they react with a broad range of glycosyl acceptors with very good
stereochemical control. These donors have proved to be more versatile glycosylating
agents because of their higher reactivity with nucleophiles under mild conditions.
Trichloroacetimidate donors with participating groups at C-2 yield 1,2-trans-compounds,
as would be expected. The mannosyl trichloroacetimidate donor was conveniently
synthesized in three steps as shown in Scheme 16.

Scheme 16. Synthesis of trichloroacetimidate donor 12.
Following Tosin and Murphy’s procedure,80 penta-O-acetyl-α/β-D-mannoside (2)
was anomerically deacetylated using BnNH2 in THF in an overnight reaction. The
anomeric-OH of 2,3,4,6-tetra-O-acetyl-D-mannopyranose (11) was readily converted into
the corresponding trichloroacetimidate (12) by the well-documented Schmidt
procedure.62 Having synthesized the acceptor and donor, the stage was now set for
glycosylation.
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1.4. Synthesis of α-(1→2)-linked disaccharides 13 and 14
The glycosylation step is always considered the biggest challenge throughout an
oligosaccharide synthesis. There have been various methods for glycosylation reactions;
however, the most widely used one is without a doubt Schmidt’s trichloroacetimidate
procedure.62 The typical reaction conditions involve the use of 4 Å molecular sieves as a
drying agent before the moisture-sensitive trimethylsilyl triflate is applied. This treatment
was critical to the success of our glycosylation reactions after various unsuccessful
attempts. Since the triflate catalyst is very moisture sensitive, it was quenched by the
traces of moisture in the flask shortly after addition, resulting in no glycosylation. After
we realized the importance of an absolute moisture-free environment in this reaction, we
took the effort to pulverize and activate the commercially packaged molecular sieves.
Molecular sieves were heated in a flask at 250 ºC for 4 h under vacuum. The reaction was
more successful when the pulverized and dried molecular sieves were used. However, the
yield remained low for some unknown reasons.
A premix–predry technique used by other chemists was also adopted, and the
yield improved to a modest 44%. In this technique, the acceptor and donor are mixed and
dried for some days before the glycosylation reaction to remove all traces of moisture.
TMSOTf was commercially packaged and sold in a vial without septum, moisture crept
into the vial each time it was opened for use and quenched the TMOSTf. It then became
very important to distill TMSOTf and store it in a vial capped with a septum and
protected from moisture. With all these treatments, a 54% yield was achieved.
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Glycosylation of trichloroacetimidate donor 12 and acceptor 8 was achieved
following Schmidt’s procedure (Scheme 17).62 Evidence from NMR spectroscopy and
mass spectrometry showed that two main products 13 and 14 were formed. The expected
fully protected disaccharide 13 was formed alongside a disaccharide with a free3-OH
group 14. The p-methoxybenzyl (PMB) protective group was cleaved when the reaction
mixture was warmed to room temperature during the glycosylation process to afford
disaccharide 14. To be sure that the PMB group was not cleaved prior to the
glycosylation process, the reaction was repeated. This time, the reaction was closely
monitored by TLC and upon complete consumption of the acceptor; the reaction was
quenched at -20 ºC with the addition of Et3N. Evidence from NMR spectroscopy and
mass spectrometry showed that the PMB protective group was not cleaved and that the
fully protected disaccharide 13 was the only product formed.

Scheme 17. Synthesis of α-(1→2)-linked disaccharides 13 and 14.

In order to install the thiol functionality, it was important to protect the free
hydroxyl group (3-OH). This is because there should be no active hydrogen on the
compound as this will react with 1,2-ethanedithiol. Treatment of disaccharide 14 with
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acetic anhydride in the presence of pyridine and 4-(dimethyamino)pyridine (DMAP)
afforded the fully pentaacetylated disaccharide 15 in 81% yield (Scheme 18).
Disaccharide 15 was fully characterized using 2D NMR techniques (gCOSY, HSQC,
HMBC) to prove the α-(1→2)-linkage. Now that the free 3-OH of the disaccharide has
been temporarily protected, the thiol functionality could be introduced by radical
addition. Following procedure by Vliegenthart and co-workers,65 disaccharide 15 was
treated with 1,2-ethanedithiol in 1,4-dioxane, and after free-radical initiation by AIBN
and three hours heating, extended thiol compound 16 was produced in 78% yield.
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Scheme 18. Synthesis of the free α-(1→2)-linked disaccharide 18.
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The benzylidene protective group was removed by treatment of thiol-terminated
disaccharide 16 with 90% of aqueous trifluoroacetic acid (TFA).81 Without further
characterization, global deprotection of diol (17) under Zemplén conditions gave the
thiol-terminated mannose-bearing disaccharide 18 in pure form after purification on an
LH-20 column. 1H and

13

C NMR analyses of the product confirmed that it was 3-[(2-

sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-α-D-mannopyranoside (18),
the desired disaccharide.

1.5. Synthesis of α-(1→3)-linked disaccharide 19
The synthesis of (1→3)-linked disaccharide commenced with the diol 7 as the acceptor
and trichloroacetimidate donor 12. The 3-OH group of diol 7 was more accessible for
glycosylation since it was oriented in the equatorial position and than the 2-OH that was
axial. Using this to our advantage, a glycosylation reaction was carried out between the
diol 7 and trichloroacetimidate donor 12 at -40 ºC for 2 h under an N2 atmosphere
(Scheme 19). The diol 7 was not readily soluble in DCM, so it was sonicated for ~ 1 h
prior to glycosylation.

Scheme 19. Synthesis of α-(1→3)-linked allyl disaccharide 19.
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This afforded α-(1→3)-linked disaccharide 19 in 62% yield alongside a 10% yield
of trisaccharide. The structure of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→3)-4,6-O-benzylidene α-D-mannopyranoside (19) was confirmed by 1D and 2D
NMR spectroscopy (gCOSY, gHSQC, TOCSY, HMBC). The disaccharide was
acetylated using Ac2O and pyridine to mask the active hydrogen on the hydroxyl group
(Scheme 20). Following the procedure by Vliegenthart and co-workers,65 the thiolterminus was installed on compound 20 using 1,2-ethanedithiol in a free-radical reaction
with AIBN in 1,4-dioxane. This radical reaction led to the formation of 3-[(2sulfanylethyl)sulfanyl]propyl

2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-2-O-

acetyl-4,6-O-benzylidene-α-D-mannopyranoside (21) in 63% yield.

Scheme 20. Installation of thiol terminal on the (1→3)-linked disaccharide.

Deprotection of the benzylidene acetal was readily effected by treatment of thiolterminated disaccharide 21 with 60% aqueous acetic acid at 65 ºC to provide a diol
intermediate. For ease of purification and characterization, the diol intermediate 22 was
acetylated (Scheme 21). Transformation of the diol intermediate into the heptaacetate 23
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was carried out using Ac2O in pyridine with DMAP catalyst. Finally, global deprotection
through Zemplén deacetylation afforded final disaccharide 24 in 64% yield.

Scheme 21. Synthesis of the free α-(1→3)-linked disaccharide 24.
Having synthesized both (1→2)-linked and (1→3)-linked disaccharides, we
turned our attention to the synthesis of a trisaccharide with combined features of both
disaccharides.

1.6. Synthesis of thiol-terminated trisaccharide 25
The (1→2)-linked disaccharide 14 with open 3-OH served as the acceptor (for synthesis
of acceptor refer back to Scheme 17) for the synthesis of the trisaccharide 25. When a
satisfactory amount of this disaccharide was obtained, glycosylation was carried out with
a trichloroacetimidate donor 12 (Scheme 22) to afford the trisaccharide 25 in 59% yield.
This thiol-terminated trisaccharide was characterized extensively via 1D (1H and 13C) and
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2D (gCOSY, HSQC, TOCSY, HMBC, NOESY) NMR spectroscopy (for spectra, refer to
Appendix).

Scheme 22. Synthesis of allyl trisaccharide 25.
All 1H and

13

C chemical shifts were assigned based on collective 2D data.

Heteronuclear single quantum correlation (HSQC) relates the chemical shift of a proton
with the chemical shift of the directly bonded carbon. HSQC data was first used to
account for all protonated carbons and their respective protons. Gradient correlation
spectroscopy (gCOSY) data was next used to determine the protons that coupled with the
anomeric protons, since the anomeric protons only have one neighboring proton with
which they couple. A heteronuclear multiple bond correlation (HMBC) NMR experiment
utilizes multiple-bond couplings over two or three bonds (J = 2–15 Hz). Cross peaks are
between protons and carbons that are two or three bonds away (and sometimes up to four
or five bonds away). Thus HMBC was the perfect method for confirming the (1→2) and
(1→3)-linkages. The HMBC correlations depicted in Figure 14 were analyzed.
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Figure 14. HMBC correlations of trisaccharide 25.
Table 1 is a summary of the correlations used to assign chemical shifts for the
anomeric carbons and protons. The anomeric carbon of the reducing sugar (δ 98.65 ppm,
C-1I) was easily identified through correlation with the allylic protons (δ 4.16 and 3.99
ppm, OCH2CH=CH2). Following the same pattern, the other protons and carbons that
could be assigned as correlations were followed around each sugar unit.
Table 1. HMBC correlations of trisaccharide 25
13

δ(13C) ppm

δ(1H) ppm

δ(1H) ppm

C-1I

98.65

C-2I

77.46

3.99
OCH2bCH=CH2
5.21
H-1II

C-3I

72.41

C-1II

99.48

4.16
OCH2aCH=CH2
4.89
H-1I
5.30
H-1III
4.06
H-2I

C
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Allyl

2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-D-

mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25) was treated with
1,2-ethanedithiol in 1,4-dioxane, after free-radical initiation by AIBN (Scheme 23)
following the well-established Vliegenthart method.65 This led to the formation of the
thiol-terminated trisaccharide 26 in a high yield of 78%.

Scheme 23. Synthesis of free thiol-terminated trisaccharide 29.
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At room temperature, thiols easily oxidize to form dithiols; however, the MALDI-TOF
mass spectrum (Figure 15) of the compound 26 did not indicate a dithiol as shown by m/z
1085.2979 corresponding to [M+Na]+ (calcd for [M+Na]+ m/z 1085.2970). Opening of
the benzylidene acetal using 90% TFA at room temperature afforded the diol
intermediate 27. For easy purification and characterization, the diol was temporarily
protected by acetylation with Ac2O in pyridine. The reaction was started cold at -10 ºC
and slowly warmed up to room temperature. To improve the yield, DMAP was added to
the reaction mixture to afford the trisaccharide 28 in a near quantitative yield of 82%.
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Figure 15. MALDI-TOFMS characterization of thiol-terminated
trisaccharide 26.

The thiol functionality was acetylated during the acetylation process, and this was
confirmed by the 1H and 13C NMR data showing an extra CH3 peak at δ 30.77 ppm and
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an extra carbonyl carbon at δ 195.47, respectively. Deacetylation of the resulting
trisaccharide with NaOMe in 1:5 DCM–MeOH provided the target thiol-terminated
trisaccharide 29. The product was purified on an LH-20 column with water and methanol
to afford pure compound 29 as a colorless oil.

2. Synthesis of Alkyne Derivatized Mannose Sugars
2.1. Synthesis of an alkyne-derivatized monosaccharide 30
The propargyl-terminated monosaccharide 30 was synthesized in one step according to
the procedure developed by Rajput and co-workers (Scheme 24).82 Commercially
available mannose (1) was heated at 65 ºC with propargyl alcohol in the presence of
H2SO4-activated silica gel for 2.5 h. This produced a mixture of 65% α-anomer and 35%
β-anomer and separation of these anomers was difficult since they ran too close to each
other on TLC. The mixture was acetylated for easier purification.

Scheme 24. Synthesis of free alkyne-terminated monosaccharide 30.
The yield after acetylation was lower than expected, so an alternate approach was
used to synthesize the target monosaccharide as shown in Scheme 25. A solution of
previously synthesized pentaacetate 2 in DCM was reacted with propargyl alcohol and
BF3·OEt2 to afford propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (31).83
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Deacetylation of 31 was achieved under Zemplén conditions to afford the known
monosaccharide 30 with a high yield of 88%.

Scheme 25. Synthesis of free alkyne-terminated monosaccharide 30.
The product was recrystallized from EtOH to obtain pure colorless crystals of
propargyl α-D-mannopyranoside (30). Having synthesized the monosaccharide, our
attention was turned to the synthesis of the disaccharide.

2.2. Synthesis of an alkyne-derivatized acceptor 33
The synthetic methods used for the synthesis of allyl acceptor 8 (Scheme 13) were
adopted for the synthesis of the propargyl acceptor 33. The synthesis of the acceptor
commenced with the installation of the benzylidene protecting group on the
monosaccharide 30 (Scheme 26). The resulting propargyl 4,5-O-benzylidene-α-Dmannopyranoside (32) was selectively protected at the 3-O-position with a pmethoxybenzyl group to afford the required the 2-ol acceptor 33 in 65% yield as a
viscous gel.
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Scheme 26. Synthesis of alkyne-terminated acceptor 33.
2.3. Synthesis of thio-ether donor 34
The propargyl acceptor was isolated as a very viscous oil that trapped moisture; it
required a long time to dry even under high vacuum. The pre-mix and pre-dry technique
with

trichloroacetimidate

prior

to

glycosylation

was

unsuccessful.

The

trichloroacetimidate is known to be unstable at room temperature and was not suitable for
glycosylation with the propargyl acceptor. Contrarily, thioglycoside donors are more
stable at room temperature. The thioglycosides differ from O-glycosides in their reactions
with several electrophiles since they complex with a range of sulfur-specific reagents to
form sulfonium cations which, as good leaving groups, are readily displaced.
Consequently, thioglycosides have become valuable intermediates in a variety of
transformations, notably glycosylations.84 Thiophilic metal salts of mercury(II), lead(II),
copper(II) and silver(I) were originally the most popular activators for these reactions.84
In the presence of the Lewis acid BF3·OEt2 and ethanethiol, pentaacetate 2 was converted
to the thioglycoside donor 34 in a 65% yield (Scheme 27).85
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Scheme 27. Synthesis of thioglycoside donor 34.

2.4. Synthesis of an α-(1→2)-linked alkyne-derivatized disaccharide 38
The propargyl acceptor 33 was coupled with known thioglycoside donor 34 using NIS in
the presence of silver triflate (AgOTf) at -20 ºC as shown in Scheme 28.86 After complete
conversion of the acceptor, the temperature of the solution was raised to room
temperature, and the mixture was stirred for an additional hour, at which time the pmethoxybenzyl group was cleaved to furnish the target disaccharide 35 in 61% yield.

Scheme 28. Synthesis of an α-(1→2)-linked propargyl disaccharide
MALDI-TOF mass spectrometry data (Figure 16) confirmed that the p-methoxybenzyl
group was cleaved at room temperature showing m/z 659.3515 corresponding to
[M+Na]+and m/z 675.2224 corresponding to [M+K]+.
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Figure 16. MALDI-TOFMS characterization of the alkyne-terminated
disaccharide 35.
For easier characterization, the disaccharide 35 was acetylated with Ac2O in the
presence of pyridine to afford 36 in a nearly quantitative yield (Scheme 29). The
benzylidene protecting group was removed by heating compound 36 in a solution of 60%
aqueous acetic acid at 65 ºC for 45 minutes. The resulting diol intermediate was
acetylated for easier purification and characterization to afford compound 37. There were
now seven acetate protecting groups on the disaccharide as confirmed by their 1H and 13C
NMR spectra. Finally, global deprotection of heptaacetate 37 furnished the target
disaccharide 38 in 59% yield (as shown in scheme 29).
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Scheme 29. Synthesis of the free (1→2)-linked alkyne-terminated
disaccharide 38.
2.5. Synthesis of alkyne-derivatized trisaccharide 42
The synthesis of alkyne derivatized trisaccharide 39 began with 3-OH free disaccharide
acceptor 35 (for synthesis of disaccharide, refer to Scheme 28) as shown in Scheme 30.
Glycosylation of acceptor 35 and thioglycoside donor 34 was achieved through thioether
activation with NIS and AgOTf at -20 ºC for 2 h. The reaction proceeded smoothly to
furnish the protected trisaccharide 39. The desired α-(1→3)-link was the major product,
but the β-anomer was also formed and had a smaller Rf than the α-anomer on the TLC
plate. Purification by column chromatography led to the separation of products with an
α:β ratio of 4:1. All 1H and 13C chemical shifts were assigned using extensive 2D NMR
data.
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Scheme 30. Synthesis of alkyne-terminated trisaccharide 39.
Opening of the benzylidene acetal was achieved by heating the trisaccharide 39
with 60% aqueous acetic acid at 65 ºC to afford the diol intermediate 40 (Scheme 31).
For ease of purification and characterization, the diol was acetylated with Ac2O in the
presence of pyridine and DMAP catalyst to furnish the trisaccharide 41.

Scheme 31. Synthesis of the free alkyne-terminated trisaccharide 42.
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The resulting acetylated trisaccharide was fully characterized by 1D and 2D
(gCOSY, HSQC, HMBC, TOCSY) NMR analysis. However, it was very difficult to
assign chemical shifts to the different protons and carbons due to extensive overlap of the
NMR signals. To resolve this problem, an HSQC-TOCSY (Heteronuclear Single
Quantum Coherence-Total Correlation Spectroscopy) NMR experiment was employed.
HSQC-TOCSY is a 2D TOCSY NMR experiment that has been resolved into the carbon
dimension. This is especially useful when overlap in the proton spectrum prevents
analysis since often the corresponding carbons will be resolved. Cross peaks are seen
between all J-coupled protons in a spin system and each carbon in that spin system.87
Changing the mixing time for each experiment allows for a sequential acquisition of data.
Hence three HSQC-TOCSY experiments were carried out with different mixing times of
24 ms, 50 ms and 80 ms. Previously acquired 2D NMR data and the newly acquired data
(all NMR data as well as tables of HSQC and HMBC correlations are found in the
Appendix) clearly showed three ring systems as shown with different colors in Figure 17.
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Figure 17. Three ring systems of the alkyne-terminated trisaccharide 41.

The first HSQC-TOCSY experiment (24 ms) showed correlations between
anomeric protons and their neighboring protons (H-2). The second experiment (50 ms)
showed more correlations extending to H-3 and H-4. The last experiment (84 ms) showed
complete correlations from anomeric proton (H-1) to H-6 for each ring system. The
HSQC-TOCSY correlations are shown in Table 2.
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Table 2. HSQC-TOCSY correlations of trisaccharide 41.
13

δ( C) ppm

δ(1H) ppm

55.07
62.22
62.50
62.95
66.21
66.46
66.69
68.71
68.73
69.35
69.46
69.63
69.76
69.76
75.71
77.36
78.48
96.78
99.34
99.47

4.23
4.11, 4.20
4.24, 4.17
4.28, 4.03
5.21
5.30
5.38
5.27
5.40
4.09
4.21
3.85
5.13
5.30
2.47
4.10
4.07
5.25
5.09
4.97

OCH2C≡H
H-6, H-6’
H-6, H-6’
H-6, H-6’
H-4
H-4
H-4
H-3
H-3
H-5
H-5
H-5
H-2
H-2
≡CH
H-3
H-2
H-1
H-1
H-1

Type of
carbon
CH2
CH2
CH2
CH2
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH
CH

CH3

2.14
2.08
2.06
2.04
2.03
2.10
1.96
1.98

2.11
2.12

Another advantage of using HSQC-TOCSY NMR is that even the CH3 can be
assigned to their specific ring systems (Table 1). With the structure of compound 41 now
confirmed, it was deacetylated using methanolic NaOMe under Zemplén conditions to
afford the target free alkyne derivatized trisaccharide 42 in 80% yield.63
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3. Synthesis of a Dimeric Mannose Derivative
3.1 First attempt to synthesize dimeric mannose derivative 48
Trichloroacetimidate donor 12 (three equivalents) was used in a glycosylation reaction
with diethylene glycol (43) serving as the acceptor (Scheme 32).

Scheme 32. First attempt to synthesize the dimeric mannose derivative 44.

The desired disaccharide 44 was not formed, and the isolated product turned out
to be the hydrolyzed donor. This could be attributed to the quenching of the promoter
TMSOTf by traces of water in the diethylene glycol. The pre-mix and pre-dry technique,
addition of molecular sieves, did not completely get rid of all traces of moisture.
Diethylene glycol is very viscous; it locks in moisture and impurities which are difficult
to remove even under high vacuum. After all efforts to dry the sample for glycosylation
failed, a new stepwise approach was used.
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3.2 Second attempt to synthesize dimeric mannose derivative 48
The step-wise approach used to synthesize dimeric mannose derivative commenced with
mono-benzylation of the commercially available diethylene glycol 43 (Scheme 33). A
mixture of diethylene glycol (43), BnBr and Ag2O (Lewis acid) in DCM was stirred at
room temperature for 14 h according to the procedure developed by Sauvé and coworkers.88

Scheme 33. Synthesis of ethylene glycol-linked moosaccharide 47.

The mono-benzylated diethylene glycol 45 was used in a glycosylation reaction
with the trichloroacetimidate donor 12 in the presence of 4 Å molecular sieves and
TMSOTf. This furnished the desired diethylene glycol-linked monosaccharide 46 in a
39% yield. Using 20% Pd(OH)2/C,89 the benzyl group was removed under an H2
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atmosphere

to

afford

2-(2-hydroxyethoxy)ethyl

2,3,4,6-tetra-O-acetyl-α-D-

mannopyranoside (47) in an 80% yield. This newly deprotected monosaccharide 47 could
serve as the acceptor for the formation of the dimeric mannose derivative 44 (Scheme
34). Acceptor 47 was coupled with trichloroacetimidate donor 12 in the presence of
TMSOTf promoter to furnish dimeric sugar 44. From the 1H NMR spectrum, the J1,2
coupling constant was determined to be 1.6 Hz confirming an α-(1→1)-linked dimeric
sugar. The free dimeric sugar 48 was synthesized from compound 44 under Zemplén
conditions using freshly made NaOMe from Na(s) and MeOH.63

Scheme 34. Synthesis of free dimeric mannose derivative 48.
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IV. Conclusion and Future Work
A dimeric mannose derivative 48 was synthesized for use in the development of methods
for detection of carbohydrate clusters. Thiol-terminal monosaccharide 5, (1→2)-linked
disaccharide 18, (1→3)-linked disaccharide 24 and trisaccharide 29 were also
synthesized for analysis of their binding properties with Con A. Alkyne derivatized
monosaccharide 30, (1→2)-linked disaccharide 38 and trisaccharide 42 were successfully
synthesized for applications in click chemistry. These compounds (Figure 18) were
obtained via multi-step synthesis from commercially available D-mannose (1).

Figure 18. Final mannose derivatives.
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Schimdt glycosylation62 was used for the coupling reactions, and thiol terminals
were added by reaction of allyl group with ethanedithiol under free-radical conditions as
developed by Vliegenthart and coworkers.65 These disaccharides and trisaccharides have
two different branching patterns, the α-(1→2)-linkage and the α-(1→3)-linkage. Future
work will include synthesis of alkyne-derivatized galactosides with similar linkages.
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V. Experimental
General methods: 1H (300 MHz, 500 MHz, 600 MHz) NMR spectra were recorded at
room temperature with a Mercury 300, Varian 500 and Innova 600 instruments,
respectively.

13

C spectra were recorded at 75 MHz, 126 MHz and 150 MHz,

respectively, on the same instruments. Chemical shifts are reported in δ-units (ppm)
relative to the internal standard tetramethylsilane (TMS) for 1H (δ 0) and CDCl3 for 13C (δ
7.26), unless otherwise indicated. Multiplicities are first-order values in Hz: s, singlet; bs
broad singlet; d, doublet; dd, doublet of doublet; t, triplet; dt, doublet of triplet; ddd
doublet of doublet of doublet; m, multiplet. All two-dimensional experiments (gCOSY,
gHSQC, gHMBC, NOESY and TOCSY) were recorded on either a Varian 500 or Inova
600 MHz instruments. All NMR resonance assignments were confirmed by 2D NMR
techniques. MALDI-TOF mass spectra were obtained on a Voyager-DE PRO
BioSpectrometry workstation. High-resolution DART mass spectra were obtained on a
JEOL AccuTOF-DART workstation with an ESI source. All reactions were monitored by
thin-layer chromatography (TLC) on aluminum-backed E. Merck Silica Gel 60 F254
plates (0.25 mm). Detection was by UV irradiation using a 254 nm lamp and then
charring with p-anisaldehyde–sulfuric acid stain reagent. Column chromatography was
performed on 60 Å (63−200 µm) and 40 Å (40−60 µm) silica gel. All chemicals used
were reagent grade and used as supplied unless noted otherwise. All reactions were
performed in oven-dried glassware under an inert N2 atmosphere unless noted otherwise.
Reagent grade dichloromethane (DCM), tetrahydrofuran (THF), methanol (MeOH), N,N71

dimethylformamide (DMF)

and toluene were obtained dry from the Pure Solv

(Innovation Technologies) solvent system. Pyridine and Et3N were distilled over CaH2
prior to use. Organic extracts were dried over anhyd magnesium sulfate (MgSO4).

General procedure 1: acetylation65
To a cooled mixture (0 ºC) of mannose derivative in dry pyridine were added 2 molar
equiv of Ac2O and 0.1 molar equiv of 4-dimethylaminopyridine (DMAP). The reaction
mixture was stirred overnight and allowed to warm up slowly to room temperature. The
reaction was quenched by dilution with water, and the mixture was concentrated. The
concentrate was extracted with EtOAc; the extract was washed with water and then brine.
After separation and drying over MgSO4, the organic phase was concentrated to dryness.
Co-evaporation of the residue under vacuum with toluene afforded the dry product. The
products were purified by flash chromatography on silica gel.

General procedure 2: deacetylation90
To a solution of the acetylated mannose derivative in dry 1:5 CH2Cl2–MeOH was added
0.3 molar equiv of NaOMe (25 wt % in MeOH). The reaction was allowed to stir at room
temperature for 3–5 h, after which time it was neutralized with Dowex-50 (H+ form),
filtered, and concentrated.
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General procedure 3: free-radical addition of thiol65
To a stirred solution of allylated mannopyranoside in 1,4-dioxane was added 10 molar
equiv of 2-mercaptoethanethiol and 3 molar equiv of AIBN. The mixture was stirred for
3 h at 75 °C under N2 and quenched with 5 molar equiv of cyclohexene for 30 min. After
cooling to room temperature, the mixture was concentrated.

General procedure 4: glycosylation A81
The glycosyl acceptor (1 molar equiv) and trichloroacetimidate donor (1.5 molar equiv)
were premixed and predried under high vacuum for 1 day. The mixture was then
dissolved in anhyd DCM (to make a 0.5 M solution) and activated powdered 4 Å
molecular sieves were added. The solution was stirred at room temperature for 30–50 min
under an N2 atmosphere and then cooled to -20 °C. TMSOTf (0.1 molar equiv) was
diluted into 0.5–1 mL of anhyd DCM and added dropwise to the solution. The reaction
mixture was stirred for 2–3 h while monitoring by TLC for the complete consumption of
the acceptor. Upon completion of reaction, the mixture was neutralized with Et3N (0.1
molar equiv), filtered through a pad of Celite and concentrated under reduced pressure to
dryness.

General procedure 5: glycosylation B
The glycosyl acceptor (1 molar equiv) and 2 molar equiv of trichloroacetimidate donor
were premixed with dry DCM and pre-dried for a day under vacuum. To a stirred
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solution of the donor and acceptor in dry DCM (0.5 M solution) was added powdered 4 Å
molecular sieves, the mixture was stirred at room temperature for 30–50 min under an N2
atmosphere. The mixture was cooled to -20 ºC and 0.1 molar equiv of TMSOTf was
added. The reaction was monitored by TLC and was warmed up to room temperature
upon complete consumption of the acceptor. After stirring at room temperature for 1–2 h,
the reaction was quenched with Et3N (0.1 molar equiv). The solution was filtered through
a pad of Celite and concentrated; the crude product was purified by silica gel column
chromatography.

General procedure 6: glycosylation C86
The glycosyl acceptor (1 molar equiv) and 2 molar equiv of thioglycoside donor were
premixed with dry DCM and pre-dried for 2 days under vacuum. To a stirred suspension
of donor and acceptor in dry DCM (0.5 M solution) was added powdered 4 Å molecular
sieves and the mixture stirred at room temperature for 1 h under an N2 atmosphere. The
mixture was cooled to -20 ºC and 0.1 molar equiv of AgOTf and 1 molar equiv of NIS
were added. Reaction was monitored by TLC, and after complete consumption of the
acceptor, the reaction was warmed up to room temperature. After stirring at room
temperature for 1 h the reaction was quenched with TEA (0.1 molar equiv), filtered
through Celite, concentrated and purified by silica gel column chromatography.
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General procedure 7: removal of benzylidene protecting group A81
The mannose derivative was dissolved in 9:1 TFA–H2O to make a 0.1 M solution. The
mixture was stirred at room temperature for 1–2 h while monitoring by TLC. Upon
completion of the reaction, the solution was concentrated to dryness and the residue was
extracted with DCM.

General procedure 8: removal of benzylidene B82
The mannose derivative was dissolved in 80% AcOH to make a 0.05 M solution. The
mixture was heated at 80 ºC for 2 h with monitoring by TLC. Upon completion of
reaction, the solution was concentrated to dryness and extracted with DCM.

1,2,3,4,6-Penta-O-acetyl-D-mannopyranose (2)

A mixture of NaOAc (5.02 g, 60.5 mmol) and Ac2O (50.0 mL, 526 mmol) was heated
under an N2 atmosphere to 70 °C. D-Mannose (1, 10.0 g, 55.6 mmol) was slowly added to
the mixture, and the temperature was raised to 90 °C and stirred for 8 h. The reaction was
cooled to room temperature, poured into ice (1000 g) and quenched with 1 L of satd
NaHCO3. The aq phase was extracted three times with CH2Cl2. The organic extract was
washed successively with water and brine, then dried over MgSO4 and concentrated.
Purification of the product by column chromatography on a silica gel column (2:1
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hexane–EtOAc) gave compound 2 (19.5 g, 90.1%) as a viscous oily mixture of 65% α
and 35% β anomers. 1H NMR for α anomer (CDCl3, 300 MHz): δ 6.08 (d, J1,2 = 1.52 Hz,
1H, H-1), 5.34 (m, 2H, H-3, H-4), 5.26 (m, 1H, H-2), 4.27 (dd, J6a,6b = 12.38 Hz, J5,6 =
4.89 Hz, 1H, H-6a), 4.10 (dd, J6a,6b = 12.38 Hz, J5,6b = 2.35 Hz, 1H, H-6b), 4.05 (m, 1H,
H-5), 2.17, 2.16, 2.09, 2.05, 2.00 ( 5s, 15H, 5 COCH3). 13C NMR for α anomer (CDCl3,
125 MHz): δ 170.53, 169.88, 169.63, 169.43, 167.96, (5C, 5 COCH3), 90.54 (C-1), 70.55
(C-5), 68.67 (C-3), 68.27 (C-2), 65.49 (C-4), 62.04 (C-6), 20.78, 20.68, 20.63, 20.58,
20.55 (5C, 5 COCH3). The spectroscopic data matched that previously reported.91

Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (3)

Under an N2 atmosphere, 18.0 g (46.2 mmol) of the pentaacetate 2 was dissolved in 100
mL of dry CH2Cl2 and 19.0 mL of allyl alcohol (278 mmol) was added. While stirring,
the mixture was cooled to -5 °C. BF3·Et2O (119 mL, 884 mmol) was added dropwise into
the solution. The solution was stirred at 0 °C for 30 min, then warmed up to room
temperature and stirred for 51 h. The reaction was quenched by pouring it into ice water,
and the two phases were separated. The organic layer was washed with water, satd
NaHCO3 and brine; and then it was dried over anhyd MgSO4. The solution was filtered
through a Celite bed and concentrated. The residue was passed through a short silica gel
column with 2:1 hexane–EtOAc as the eluent to yield pure 3 as a colorless oil (11.86 g,
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66%): 1H NMR (300 MHz, CDCl3): δ 5.98–5.76 (m, 1H, OCH2CH=CH2), 5.34 (dd, J3,4 =
10.01 Hz, J2,3 = 3.42 Hz, 1H, H-3), 5.31–5.27 (m, 1H, OCH2CH=CH2), 5.24 (m, 1H, H4), 5.20 (m, 2H, H-2, OCH2CH=CH2), 4.83 (d, J1,2 = 1.58 Hz, 1H, H-1), 4.25 (dd, J6a,6b =
12.23 Hz, J5,6a = 5.27 Hz, 1H, H-6a), 4.20–4.11 (m, 1H, OCH2CH=CH2), 4.07 (dd, J6a,6b
= 12.22 Hz, J5,6b = 2.43 Hz, 1H, H-6b), 4.04–3.99 (m, 1H, OCH2-CH=CH2), 3.99–3.94
(m, 1H, H-5), 2.12, 2.07, 2.01, 1.96 (4s, 12H, 4 CH3COO). 13C NMR (75 MHz, CDCl3):
δ 170.50, 169.91, 169.74, 169.61 (4C, 4 CH3COO), 132.83 (OCH2CH=CH2), 118.33
(OCH2CH=CH2), 96.49 (C-1), 69.53 (C-3), 68.98 (C-4), 68.55 (C-5), 68.46
(OCH2CH=CH2), 66.10 (C-2), 62.37 (C-6), 20.78, 20.70, 20.63, 20.59 (4C, 4 COCH3).
The spectroscopic data was consistent with that previously reported.92

3-[(2-Sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (4)

Following general procedure 3, a mixture of 3 (2.50 g, 6.44 mmol), ethanedithiol (5.40
mL, 64.4 mmol), dioxane (50 mL), and AIBN (5.28 g, 32.2 mmol) was stirred under an
N2 atmosphere at 75 °C for 2.5 h. Cyclohexene (3.30 mL, 32.2 mmol) was added to
quench the reaction. The solution was concentrated and purified by column
chromatography on silica gel with 2:1 hexane–EtOAc as the eluent to yield pure 4 (1.90
g, 61%). [α]D = +38.8º (c = 1.0 in CHCl3). 1H NMR (500 MHz, CDCl3): δ 5.30 (dd, J3,4
= 10.03 Hz, J2,3 = 3.36 Hz, 1H, H-3), 5.25 (t, J3,4 = J4,5 = 9.89 Hz, 1H, H-4), 5.21 (dd, J2,3
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= 3.14 Hz, J1,2 = 1.69 Hz, 1H, H-2), 4.79 (d, J1,2 = 1.69 Hz, 1H, H-1), 4.25 (dd, J6a,6b =
12.23 Hz, J5,6a = 5.32 Hz, 1H, H-6a), 4.10 (dd, J6a,6b = 12.23 Hz, J5,6b = 2.29 Hz, 1H, H6b), 3.97 (ddd, J4,5 = 9.04 Hz, J5,6a = 5.21 Hz, J5,6b = 2.26 Hz, 1H, H-5), 3.80 (m, 1H,
OCH2CH2CH2S), 3.52 (m, 1H, OCH2CH2CH2S), 2.72 (m, 4H, SCH2CH2SH), 2.63 (m,
2H,

OCH2CH2CH2S), 2.13, 2.08, 2.02, 1.97 (4s, 12H, 4 COCH3), 1.87 (m, 2H,

OCH2CH2CH2S), 1.70 (m, 1H SH).
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C NMR, (125 MHz, CDCl3): δ 170.53, 169.97,

169.80, 169.63 (4C, 4 COCH3), 97.52 (C-1), 69.52 (C-2), 69.01 (C-3), 68.54 (C-5),
66.32 (OCH2CH2CH2S), 66.13 (C-4), 62.43 (C-6), 36.13 (SCH2CH2SH), 29.03
(OCH2CH2CH2S), 28.49(OCH2CH2CH2S), 24.61(SCH2CH2SH), 20.81, 20.69, 20.63,
20.61 (4 COCH3). MALDI-TOFMS: calcd for C19H30O10Na [M+Na],+ m/z 505.1178;
found m/z 505.1207.

3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranoside (5)

Following general procedure 2, 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-Oacetyl-α-D-mannopyranoside (4, 1.90 g, 3.94 mmol) was deacetylated in dry CH2Cl2 (5
mL) and MeOH (25 mL) using NaOMe (0.06 g, 1.18 mmol). The crude product was
purified on an LH-20 column to give pure product 5 as a colorless oil (1.04 g, 84%). [α]D
= +50.5º (c = 1 in H2O). 1H NMR (300 MHz, CD3OD): δ 4.76 (d, J1,2 = 1.56 Hz, 1H, H1), 3.83 (m, 3H, H-2, H-3, H-5), 3.71 (m, 2H, H-6a,b), 3.62 (t, J3,4 = J4,5 = 9.25 Hz, 1H,
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H-4), 3.53 (m, 2H, OCH2CH2CH2S), 2.93 (ddd, 2H, SCH2CH2SH), 2.84 (m, 2H,
SCH2CH2SH), 2.67 (t, 2H, OCH2CH2CH2S), 1.89 (m, 2H, OCH2CH2CH2S).

13

C (75

MHz, CD3OD): δ 101.63 (C-1), 74.66 (C-5), 72.69 (C-3), 72.21 (C-2), 68.59 (C-4), 66.93
(OCH2CH2CH2S), 62.91 (C-6), 39.68 (SCH2CH2SH), 32.30 (OCH2CH2CH2S), 30.74
(OCH2CH2CH2S), 29.61 (SCH2CH2SH).

Allyl α-D-mannopyranoside (6)

Following general procedure 2, allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (3,
8.01 g, 20.6 mmol) in dry CH2Cl2 (20 mL) and MeOH (100 mL) was deacetylated using
NaOMe (0.33 g, 6.2 mmol). The crude product was purified on an LH-20 column to give
the pure product as a colorless oil (3.7 g, 81.7%). [α]D = +69.8º (c = 1.0, MeOH). 1H
NMR (300 MHz, CD3OD): δ 5.94 ( m, 1H, OCH2CH=CH2), 5.29 (m, 1H,
OCH2CH=CH2a), 5.17 (m, 1H, OCH2CH=CH2b), 4.80 (d, J = 1.50 Hz, 1H, H-1), 4.21
(m, OCH2aCH=CH2), 4.00 (m, 1H, OCH2bCH=CH2), 3.83 (m, 2H, H-6a, H-2), 3.72 (m,
2H, H-3, H-6b), 3.63 (t, J3,4 = J4,5 = 9.38 Hz, 1H, H-4), 3.53 (m, 1H, H-5). 13C NMR (75
MHz, CD3OD): δ 135.39 (OCH2CH=CH2), 117.31 (OCH2CH=CH2), 100.59 (C-1), 74.57
(C-5), 72.55 (C-3), 72.04 (C-2), 68.76 (OCH2CH=CH2), 68.48 (C-4), 62.78 (C-6). The
spectroscopic data matched that of the known compound.86
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Allyl 4,6-O-benzylidene-α-D-mannopyranoside (7)

A solution of allyl α-D-mannopyranoside (6, 10.0 g, 51.5 mmol), benzaldehyde dimethyl
acetal (17.60 mL, 103.1 mmol), and p-toluenesulfonic acid monohydrate (0.09 g, 0.51
mmol) in anhyd DMF (50 mL) was heated at 50 °C on a rotary evaporator under water
aspirator pressure (~22 mm Hg) for 2 h. The temperature was then increased to 65 °C,
and the mixture was concentrated in volume to 20 mL. This remaining solution was
poured into stirred slurry of ice (25 g), satd aq NaHCO3 (50 mL), and Et2O (50 mL). The
white precipitate that formed was filtered, washed with hexanes (50 mL × 3) and then
water (50 mL × 2) to give a white solid in 84% yield. [α]D = +69.7º (c = 1.0, CHCl3). 1H
NMR (500 MHz, CDCl3): δ 7.43 (m, 5H, Ar), 5.89 (m, 1H OCH2CH=CH2), 5.53 (s, 1H,
ArCH), 5.29 (m, 1H, OCH2CH=CH2a), 5.22 (m, 1H, OCH2CH=CH2b), 4.81 (d, J1,2 = 1.5
Hz, 1H, H-1), 4.23 (m, 1H, H-6a), 4.15 (ddd, 1H, OCH2aCH=CH2), 4.02 (dd, J = 9.64,
3.42 Hz, 1H, H-3), 3.92 (m, 3H, H-2, H-4, OCH2bCH=CH2), 3.81 (m, 2H, H-5, H-6b),
3.54 (bs, 2H, 2 OH).
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C NMR (125 MHz, CD3OD): δ 137.12 (Ar), 133.41

(OCH2CH=CH2), 129.09 (Ar), 128.18 (Ar × 2), 126.19 (Ar × 2), 117.56
(OCH2CH=CH2), 102.03 (ArCH), 99.49 (C-1), 78.72 (C-4), 70.84 (C-2), 68.60 (C-6),
68.39 (C-3), 68.08 (OCH2CH=CH2), 63.20 (C-5). The NMR data matched that previously
reported.84
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Allyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (8)79

To a suspension of allyl 4,6-O-benzylidine-α-D-mannose (6.02 g, 19.6 mmol) in toluene
(130 mL) was added Bu2SnO (4.91 g, 19.6 mmol). The mixture was heated to reflux for 3
h and cooled to room temperature. Tetrabutylammonium bromide (6.72 g, 21.0 mmol),
CsF (3.05 g, 20.1 mmol) and PMBCl (2.80 mL, 20.6 mmol) were added, respectively.
The mixture was stirred for 48 h and then heated to reflux for 1 h, after which it was
cooled to room temperature and washed with satd aq NaHCO3 (70 mL). The water layer
was then extracted with EtOAc (3 × 50 mL). The organic layers were combined and
washed with water and brine, and then dried over MgSO4 and filtered. The resulting
solution was concentrated, and the crude product was purified by flash chromatography
on silica gel to give a yellow oil (6.79 g, 76%). 1H NMR (300 MHz, CDCl3): δ 7.28–7.53
(m, 7H, Ar), 6.87 (m, 2H, Ar), 5.91 (m, 1H, OCH2CH=CH2), 5.62 (s, 1H, ArCH), 5.28
(m, 2H, OCH2CH=CH2), 4.89 (s, 1H, H-1), 4.80 (d, J = 11.35 Hz, 1H, OCH2aAr), 4.65
(d, J = 11.35 Hz, 1H, OCH2bAr), 3.87–4.29(m, 8H, H-2, H-3, H-4, H-5, H-6a,6b,
OCH2CH=CH2), 3.80 (s, 3H, OCH3), 2.77 (s, 1H, OH). 13C (75 MHz, CD3OD): δ 159.35
(Ar), 137.52 (Ar), 133.46 (OCH2CH=CH2), 130.06 (Ar), 129.49 (Ar × 2), 128.87 (Ar),
128.17 (Ar × 2), 126.01 (Ar × 2), 117.79 (OCH2CH=CH2), 113.82 (Ar × 2), 101.52
(ArCH), 99.12 (C-1), 78.83 (C-4), 75.32 (C-3), 72.74 (OCH2Ar), 69.95 (C-2), 68.81
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(OCH2CH=CH2), 68.12 (C-6), 63.35 (C-5), 55.22 (CH3O). The spectroscopic data
matched that previously reported.62

Allyl 2-O-acetyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (9)

A mixture of monosaccharide (8, 100 mg, 0.230 mmol) and Ac2O (65 µL, 0.69 mmol) in
pyridine (10 mL) was cooled down to -10 ºC and DMAP (3.0 mg, 0.023 mmol) was
added. The solution was stirred overnight in an N2 atmosphere as it slowly warmed up to
room temperature. The reaction was quenched by adding ice-cold water, and the mixture
was concentrated with the addition and evaporation of toluene (3 × 5 mL) from the
residue. Purification by column chromatography on silica gel (2:2:1 hexane–DCM–
EtOAc) afforded pure 9 as a colorless oil (95 mg, 86%). 1H NMR (300 MHz, CDCl3): δ
7.42 (m, 2H, Ar), 7.34–7.26 (m, 2H, Ar), 7.19 (m, 2H, Ar), 6.76 (m, 2H, Ar), 5.90–5.70
(m, 1H, OCH2CH=CH2), 5.55 (s, 1H, ArCH), 5.32 (m, 1H, H-2), 5.25–5.09 (m, 2H,
OCH2CH=CH2), 4.75 (d, J1,2 = 1.6 Hz 1H, H-1), 4.53 (q, J = 11.6 Hz, 2H, OCH2Ar),
4.23–4.15 (m, 1H, OCH2aCH=CH2), 4.09 (m, 1H, OCH2bCH=CH2), 4.01–3.87 (m, 3H,
H-3, H-4, H-5), 3.79 (dd, J = 13.2, 10.9 Hz, 2H, H-6a, H-6b), 3.71 (m, 3H, CH3OAr),
2.07 (s, 3H, COCH3). MALDI-TOFMS: calcd for C26H30O8Na [M+Na],+ m/z 493.1838;
found m/z 493.1789.
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Allyl 2-O-benzyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (10)

Following the procedure described in Chao Wang’s thesis,69 the foregoing compound 8
(500 mg, 1.17 mmol) dissolved in anhydr THF (60 mL) was added NaH (46 mg, 1.92
mmol) and stirred under an N2 atmosphere for 15 min. Benzyl bromide (0.2 mL, 1.8
mmol) was added and the solution was stirred at 60 ˚C under an N2 atmosphere for 18 h.
The resulting yellow, cloudy solution was then cooled, MeOH (2 mL) was carefully
added and the solution was stirred for 15 mins. The solvent was evaporated and the
residue was taken up in CH2Cl2, washed with water and dried with MgSO4. After
concentration, the crude product was purified by silica gel chromatography (5:1 hexane–
EtOAc) to yield pure 10 as a colorless oil (503 mg, 83%). 1H NMR (300 MHz, CDCl3): δ
7.53 (m, 2H, Ar), 7.46–7.24 (m, 10H, Ar), 6.91–6.83 (m, 2H, Ar), 5.92–5.76 (m, 1H,
OCH2CH=CH2), 5.67 (s, 1H, CHAr), 5.22 (m, 2H, OCH2CH=CH2), 4.85 (d, J1,2 = 1.6 Hz,
1H, H-1), 4.78 (m, 3H, OCH2Ar, OCH2aAr), 4.67–4.58 (m, 1H, OCH2bAr), 4.32–4.22
(m, 2H, OCH2aCH=CH2, H-4), 4.16 (ddt, J6a,6b = 13.0 Hz, J5,6a = 5.1 Hz, 1H, H-6a),
4.05–3.89 (m, 3H, H-3, H-6b, OCH2bCH=CH2), 3.88–3.79 (m, 5H, H-5, H-2, CH3OAr).
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C NMR (75 MHz, CDCl3): δ 159.17, 138.20, 137.77 (Ar × 3), 133.55 (OCH2CH=CH2),

130.83 (Ar), 129.28 (Ar × 2), 128.90 (Ar), 128.47 (Ar × 2), 128.26 (Ar × 2), 128.18 (Ar ×
2), 127.84 (Ar), 126.15 (Ar × 2), 117.65 (OCH2CH=CH2), 113.76 (Ar × 2), 101.50
(CHAr), 98.62 (C-1), 79.20 (C-4), 76.39 (C-2), 76.17 (C-3), 73.65 (CH2Ar), 72.92
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(CH2Ar), 68.90 (OCH2CH=CH2), 68.01 (C-6), 64.35 (C-5), 55.34 (CH3OAr). MALDITOFMS: calcd for C31H34O7Na [M+Na],+ m/z 541.2202; found m/z 541.2301.

2,3,4,6-Tetra-O-acetyl-D-mannopyranose (11)
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Penta-O-acetyl-α/β-D-mannopyranoside (2, 30.0 g, 76.9 mmol) and BnNH2 (16.10 mL,
146.4 mmol) in freshly distilled THF (160 mL) were stirred for 20 h at room temperature
The reaction was quenched with dilute HCl (1 M, 10 mL), the solvent was evaporated,
and the crude product was re-dissolved in CH2Cl2 and washed with water. The organic
phase was dried with anhyd MgSO4 and evaporated to dryness. The residue was
submitted to silica gel column chromatography (2:1 hexane–EtOAc) to give 2,3,4,6-tetraO-acetyl-D-mannopyranose (11) as a dark-brown oil (16.2 g, 60.5%). Spectroscopic data
for α anomer: 1H NMR (300 MHz, CDCl3): δ 5.39 (dd, 1H, J2,3 = 2.7 Hz, J3,4 = 9.6 Hz, H3), 5.27 (dd, 1H, J

3,4

= J4,5 = 9.9 Hz, H-4), 5.20-5.23 (m, 2H, H-1, H-2), 4.59–5.00 (m,

1H, OH), 4.20–4.26 (m, 2H, H-5, H-6’), 4.09–4.14 (m, 1H, H-6), 2.14, 2.08, 2.04, 1.98
(4s, 12H, 4 COCH3). 13C (75 MHz, CDCl3): δ 170.9, 170.3, 170.1, 169.8 (4s, 4 COCH3),
92.1 (C-1), 70.1 (C-2), 68.8 (C-3), 68.4 (C-5), 66.2 (C-4), 62.6 (C-6), 20.7, 20.9 (2s, 4
COCH3). The NMR data were in agreement with those described in the literature.91
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2,3,4,6-Tetra-O-acetyl-1-O-(2,2,2-trichloroethanimidoyl)-D-mannopyranose (12)

2,3,4,6-Tetra-O-acetyl-α-D-mannopyranoside (11, 5.10 g, 14.6 mmol), CCl3CN (14.6
mL, 145 mmol) and activated powdered 4Å molecular sieves (700 mg) were suspended
in anhyd DCM (100 mL) and left stirring at 0 ºC for a period of 2 h. DBU (0.43 mL, 2.88
mmol) was added. After 2.5 h of stirring at room temperature, the solution was filtered
through Celite and concentrated in vacuo. The resulting residue was purified by flash
column chromatography (1:1, hexane–EtOAc) to afford 2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl trichloroacetimidate (12, 6.3 g, 87.4%) as a clear oil. 1H NMR (300
MHz, CDCl3): δ 8.80 (s, 1H, NH); 6.29 (d, 1H, J1,2 = 1.9 Hz, H-1), 5.48 (dd, 1H, J2,3 = 2.1
Hz, H-2), 5.40–5.42 (m, 2H, H-3, H-4), 4.28 (dd, 1H, J5,6a = 4.3 Hz, J6a,6b =11.8 Hz, H6a), 4.15–4.22 (m, 2H, H-5, H-6b), 2.20, 2.07, 2.09, 2.29 (4s, 12H, 4 COCH3). 170.5,
169.8, 169.7, 169.6,159.7 (5s, 4 CO, C=NH, CCl3). 90.5 (C-1), 71.2 (C-5), 67.8 (C-2),
68.8 (C-3), 65.4 (C-4), 62.0 (C-6), 21.0, 20.7, 20.65, 20.6 (4C, 4 COCH3). The
spectroscopic data matched that of the known compound.91
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Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 4,6-O-benzylidene-3-O-(4methoxybenzyl)-α-D-mannopyranoside (13)

Following the general procedure 4, disaccharide 13 was synthesized using 1.41 g (3.29
mmol) of acceptor 8. Purification by column chromatography (2:1 hexane–EtOAc) gave
13 as a pale-yellow oil (1.2 g, 48%): %. [α]D = +22.18º (c = 1 in CHCl3). 1H NMR (300
MHz, CDCl3): δ 7.52–6.81 (m, 9H, Ar), 5.94–5.81 (m, 1H, OCH2CH=CH2), 5.68 (s, 1H,
CHAr), 5.31 (m, 5H, OCH2CH=CH2a, H-2II, H-3I, H-4II, OCH2CH=CH2a), 5.11 (d, J1,2 =
1.46 Hz, 1H, H-1II), 4.83 (d, J1,2 = 1.57 Hz, 1H, H-1I), 4.79 (d, J = 11.59 Hz, 1H,
OCH2aAr), 4.54 (d, J = 11.63 Hz, 1H, OCH2bAr), 4.32–3.61 (m, 14H, H-6aI, H-6aII,
OCH2aCH=CH2, H-3II, H-6bII, H-5II, H-2I, H-4I), OCH2bCH=CH2, H-5I, H-6bI ,OCH3),
2.05 (4 s, 12H, 4 COCH3). 13C NMR (75 MHz, CDCl3): δ 170.60, 169.93, 169.77, 169.59
(4C, COCH3), 159.05 (Ar), 137.51 (OCH2CH=CH2), 133.31 (Ar), 130.52 (Ar), 129.13
(Ar × 2), 128.85 (Ar), 128.16 (Ar × 2), 126.07 (Ar × 2), 117.71 (OCH2CH=CH2), 113.64
(Ar × 2), 101.45 (CHAr), 99.54 (C-1I), 98.89 (C-1II), 79.03, 76.82, 75.35 (C-2II, C-2I, C4I), 73.02 (OCH2Ar), 69.17, 68.99, 68.84, 68.62, 68.05, 66.28 (6C, C-3II, C-3I, C-4II, C5II, C-6I, OCH2CH=CH2), 64.08 (C-5I), 62.56 (C-6II), 55.20 (OCH3), 20.95 (COCH3),
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20.85 (COCH3), 20.82 (2C, COCH3). MALDI-TOFMS: calcd for C38H46O16Na [M+Na],+
m/z 781.2684; found m/z 781.2699.

Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-4,6-O-benzylidene-α-Dmannopyranoside (14)

Following general procedure 5, the disaccharide 14 was synthesized on an 800 mg (1.87
mmol) acceptor scale. Purification by column chromatography (2:1 hexane–EtOAc) gave
14 as an oil (500 mg, 42%): [α]D = +23.6º (c = 1 in CHCl3).

1

H NMR (300 MHz,

CDCl3): δ 7.46 (m, 5H, Ar), 5.90 (m, 1H, OCH2CH=CH2), 5.64 (s, 1H, CHAr), 5.33 (m,
5H, OCH2CH=CH2, H-2II, H-3I, H-4II), 5.15 (s, 1H, H-1I), 4.94 (s, 1H, H-1II), 4.17 (m,
7H, H-6aI, H-6aII, OCH2aCH=CH2, H-6bII, H-5II, H-2I), 3.90 (m,

4H, H-4I,

OCH2bCH=CH2, H-5I, H-6bI), 2.15, 2.09, 2.07, 2.01 (4 s, 12H, 4 COCH3). 13C NMR (75
MHz, CDCl3): δ 170.54, 170.00, 169.81, 169.67 (4C, 4 COCH3), 137.06
(OCH2CH=CH2), 133.17 (Ar), 129.11 (Ar), 128.22 (Ar × 2), 126.17 (Ar × 2), 117.67
(OCH2CH=CH2), 101.98 (CHAr), 99.69 (C-1I), 98.54 (C-1II), 78.81 (C-2I), 78.39 (C-4I),
69.02, 68.92, 68.86, 68.58, 68.50, 68.14, 66.08 (7C, C-2II ,C-5II, C-3II, C-6I, C-3I,
OCH2CH=CH2, C-4II), 63.55 (C-5I), 62.51 (C-6II), 20.81 (COCH3), 20.70 (COCH3),
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20.65 (2C, 2 COCH3). MALDI-TOFMS: calcd for C30H38O15Na [M+Na]+ m/z 661.2108;
found m/z 661.2087.

Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 3-O-acetyl-4,6-Obenzylidene-α-D-mannopyranoside (15)

Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-3-O-acetyl-4,6-O-benzylideneα-D-mannopyranoside (15) was synthesized from 14 (450 mg, 0.705 mmol) following
general procedure 1. Yield: 390 mg, 81%. 1H NMR (300 MHz, CDCl3): δ 7.44 (m, 5H,
Ar), 5.90 ( m, 1H, OCH2CH=CH2), 5.62 (s, 1H, CHAr), 5.43 (dd, J3,4 = 10.24, J2,3 = 3.10
Hz, 1H, H-3II), 5.32 (m, 5H, OCH2CH=CH2, H-2II, H-3I, H-4II), 4.91 (d, J1,2 = 1.59 Hz,
1H, H-1I), 4.90 (d, J1,2 = 1.75 Hz, 1H, H-1II), 4.26 (m, 1H, H-6aI), 421 (m, 2H, H-6aII,
OCH2aCH=CH2), 4.16 (m, 1H, H-2I), 4.08 (m, 3H, H-6bII, H-5II, H-4I), 4.00 (dd, 1H,
OCH2bCH=CH2), 3.94 (m, 1H, H-5I), 3.88 (m, 1H, H-6bI), 2.17 (s, 3H, COCH3), 2.10 (s,
6H, 2 COCH3), 2.08 (s, 3H, COCH3), 2.04 (s, 3H, COCH3). 13C NMR (75 MHz, CDCl3):
δ 170.86, 170.54, 170.31, 170.60, 169.73 (5C, 5 COCH3), 137.66 (OCH2CH=CH2),
133.13 (Ar), 129.05 (Ar), 128.24 (Ar × 2), 126.19 (Ar × 2), 118.01 (OCH2CH=CH2),
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101.79 (CHAr), 99.67 (C-1I), 98.48 (C-1II), 77.69 (C-2I), 76.07 (C-4I), 69.78 (C-3I),
69.49 (C-2II), 69.08 (C-5II), 68.66 (C-3II), 68.61 (C-6I), 68.36 (OCH2CH=CH2), 66.23 (C4II), 63.92 (C-5I), 62.51 (C-6II), 20.87, 20.83, 20.73, 20.67 (5C, 5 COCH3). MALDITOFMS: calcd for C32H40O16Na [M+Na]+: m/z 703.2214; found m/z 703.2240.

3-[(2-Sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→2)- 3-O-acetyl-4,6-O-benzylidene-α-D-mannopyranoside (16)
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Compound 16 was synthesized following general procedure 3 using 360 mg (0.529
mmol) of the foregoing disaccharide 15. Purification on a silica gel column with 2:1
hexane–EtOAc as the eluent gave pure 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetraO-acetyl-α-D-mannopyranosyl-(1→2)-3-O-acetyl-4,6-O-benzylidene-α-D-mannopyranoside (16) as a colorless oil (320 mg, 78%). [α]D = +21.5º (c = 1 in CHCl3). 1H NMR
(300 MHz, CDCl3): δ 7.42 (m, 5H, Ar), 5.61 (s, 1H, CHAr), 5.41 (dd, J3,4 = 10.11, J2,3 =
3.25 Hz, 1H, H-3II), 5.27 (m, 3H, H-2II, H-3I, H-4II), 4.89 (1H, H-1I), 4.87 (1H, H-1II)
4.24 (m, 2H, H-6aI, H-6aII), 4.08 (m, 5H, OCH2aCH=CH2, H-2I, H-6bII, H-5II, H-4I), 3.84
(m, 3H, OCH2bCH=CH2, H-5I, H-6bI), 3.50 (m, 1H, H-6bII), 2.73 ( m, 4H, SCH2CH2SH),
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2.64 (t, J = 6.93, 6.93 Hz, 2H, OSCH2CH2CH2S), 2.16 (s, 3H, OCOCH3), 2.09 (s, 6H, 2
OCOCH3), 2.07 (s, 3H, OCOCH3), 2.03 (s, 3H, OCOCH3), 1.88 (dd, J = 13.13, 6.86 Hz,
2H, OCH2CH2CH2S), 1.72 (s, 1H, SH).

13

C NMR (75 MHz, CDCl3): δ 170.63, 170.49,

170.14, 170.06, 169.86 (5C, 5 COCH3), 137.23 (Ar), 129.17 (Ar), 128.36 (Ar × 2),
126.30 (Ar × 2), 101.88 (CHAr), 99.82 (C-1II), 99.45 (C-1I), 77.95 (C-2I), 76.12 (C-4I),
69.90 (C-3I), 69.60 (C-2II), 69.21 (C-5II), 68.75 (OCH2CH2CH2S), 66.39 (C-5I), 66.22 (C4II), 64.07 (C-6I), 62.74 (C-6II), 36.29 (SCH2CH2SH), 29.22 (OSCH2CH2CH2S), 28.68
(OCH2CH2CH2S), 24.77 64 (SCH2CH2SH), 21.00, 20.98, 20.92, 20.87, 20.85 (5C,
COCH3). MALDI-TOFMS: calcd for C34H46O16S2Na [M+Na]+ m/z 797.2125; found m/z
797.2149.

3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-α-Dmannopyranoside (18)

The benzylidene group of foregoing compound 16 (280 mg, 0.361 mmol) was removed
following general procedure 6. The resulting product was concentrated and deacetylated
following general procedure 2. The residue was redissolved in water and submitted to
LH-20 gel column chromatography to give 18 as colorless oil (113 mg, 66%). %. [α]D =
90

+8.32º (c = 1 in MeOH). 1H NMR (300 MHz, CD3OD): δ 5.07 (d, J1,2 = 1.57 Hz, 1H, H1II), H, 4.96 (d, J1,2 = 1.56 Hz, 1H, H-1I), 3.97 (dd, J = 3.06, 1.67 Hz, 1H, H-2I), 3.81 (m,
5H, H-2II, H-3I, H-4I, H-5I, H-6aI), 3.59 (m, 8H, H-5II, OCH2aCH2CH2S, H-6aII, H-6bI,
H-6bII H-4II, H-3II, OCH2bCH2CH2S), 2.92 (ddd, J = 8.51, 5.30, 1.77 Hz, 2H,
SCH2CH2SH), 2.84 (ddd, J = 7.94, 5.36, 1.92 Hz, 2H, OCH2CH2CH2S), 2.66 (t, J = 7.24,
7.24 Hz, 2H, SCH2CH2SH), 1.87 (m, 2H, OCH2CH2CH2S).
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C NMR (75 MHz,

CD3OD): δ 104.22 (C-1II), 99.93 (C-1I), 80.67 (C-2I), 75.01 (C-2II), 74.69 (C-5I), 72.40
(C-5II), 72.16 (C-3I), 71.87 (C-3II), 68.97 (C-4I), 68.81 9(C-4II), 67.02 (OCH2CH2CH2S),
63.12 (C-6I), 63.00 (C-6II), 39.58 (SCH2CH2SH), 32.22 (OCH2CH2CH2S), 30.75
(OCH2CH2CH2S), 29.57 (SCH2CH2SH). MALDI-TOFMS: calcd for C17H32O11S2Na
[M+Na]+ m/z 499.1284, found m/z 499.1305.

Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-4,6-O-benzylidene-α-Dmannopyranoside (19)

Allyl 4,6-O-benzylidene-α-D-mannopyranoside (7, 1.41 g, 4.57 mmol) was used to
synthesize disaccharide 19 following general procedure 5. Purification by column
chromatography (2:1 petroleum ether–EtOAc) gave 19 as a colorless oil (1.35 g, 46%).
[α]D = -2.16º (c = 1 in CHCl3). 1H NMR (500 MHz, CDCl3): δ 7.30 (m, 5H, Ar), 5.81 (m,
1H, OCH2CH=CH2), 5.53 (s, 1H, CHAr), 5.38 (dd, J2,3 = 3.22 Hz, J1,2 = 1.72 Hz, 1H, H91

2I), 5.34 (dd, J3,4 = 9.83 Hz, J2,3 = 3.48 Hz, 1H, H-3II), 5.32–5.17 (m, 5H, OCH2CH=CH2,
H-4II, H-1II, H-5II), 4.84 (1H, H-1I), 4.28–4.05 (m, 7H, H-3I, H-6aII, H-6aI,
OCH2aCH=CH2, H-2II, H-6bI, H-4I), 3.94 (dd, J = 12.85, 6.34 Hz, 1H, OCH2bCH=CH2),
3.79 (m, 2H, H-5I, H-6bII), 2.01 (2 s, 6H, 2 COCH3), 1.98, 1.92 ( 2 s, 6H, 2 COCH3). 13C
NMR (126 MHz, CDCl3): δ 170.73, 170.13, 169.74, 169.69 (4C, 4 COCH3), 137.22
(OCH2CH=CH2), 133.40 (Ar), 128.85 (Ar), 128.14 (Ar × 2), 126.01 (Ar × 2), 118.11
(OCH2CH=CH2), 101.42 (CHAr), 99.44 (C-1II), 98.45 (C-1I), 78.45 (C-4I), 73.95 (C-2I),
71.02 (C-3I), 69.22 (C-2II), 69.03 (C-3II), 68.99 (C-5II), 68.69 (C-6I), 68.24
(OCH2CH=CH2), 66.43 (C-4II), 63.67 (C-5I), 62.73 (C-6II), 20.76 (COCH3), 20.74
(COCH3), 20.72 (2C, 2 COCH3). MALDI-TOFMS: calcd for C30H38O15Na [M+Na]+ m/z
661.2108; found m/z 661.2137.

Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-2-O-acetyl-4,6-Obenzylidene α-D-mannopyranoside (20)

Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-4,6-O-benzylidene-α-D-mannopyranoside (19, 1.35 g, 2.11 mmol) was acetylated according to general procedure 1. The
residue was submitted to silica gel column chromatography (2:1 hexanes–EtOAc) to give
compound 20 as a white solid (1.25 g, 89%). [α]D = +6.5º (c = 1 in CHCl3). 1H NMR
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(600 MHz, CDCl3): δ 7.37 (m, 5H, Ar), 5.86 (m, 1H, OCH2CH=CH2), 5.60 (s, 1H,
CHAr), 5.34 (m, 2H, H-2I, H-3II), 5.29 (m, 1H, OCH2CH=CH2a), 5.23 (m, 2H, H-4II,
OCH2CH=CH2b), 5.19 (m, 2H, H-1II, H-5II), 4.81 (d, J = 1.14 Hz, 1H, H-1I), 4.32 (dd, J
= 9.89, 3.76 Hz, 1H, H-3I), 4.27 (m, 2H, H-6aII, H-6aI), 4.17 ( m, 1H, OCH2aCH=CH2),
4.09 ( m, 3H, H-2II, H-6bI, H-4I), 4.00 (dd, J = 12.76, 6.37 Hz, 1H, OCH2bCH=CH2),
3.86 (m, 2H, H-5I, H-6bII), 2.23, 2.08, 2.07, 2.06, 1.96 (5 s, 15H, 5 COCH3).

13

C NMR

(151 MHz, CDCl3): δ 170.78, 170.52, 170.03, 169.97, 169.85 (5C, 5 COCH3) 137.12
(OCH2CH=CH2), 133.12 (Ar), 128.99 (Ar), 128.23 (Ar × 2), 126.05 (Ar × 2), 118.57
(OCH2CH=CH2), 101.49 (CHAr), 98.32 (C-1II), 97.90 (C-1I), 79.15 (C-4I), 71.07 (C-2I),
70.89 (C-3I), 69.38 (C-2II), 69.31 (C-3II), 68.99 (C-5II), 68.66 (C-6I), 68.48
(OCH2CH=CH2), 65.81 (C-4II), 63.60 (C-5I), 62.58 (C-6II), 20.93, 20.91, 20.88, 20.84,
20.78 (5C, 5 COCH3). MALDI-TOFMS: calcd for C32H40O16Na [M+Na]+ m/z 703.2214;
found m/z 703.2206.

3-[(2-Sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→3)-2-O-acetyl-4,6-O-benzylidene-α-D-mannopyranoside (21)
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The general procedure 3 was adopted to synthesize 21 using 1.25 g (1.84 mmol) of
disaccharide 20. Yield: 900 mg, 63%. [α]D = +36.4º (c = 1 in CHCl3). 1H NMR (500
MHz, CDCl3): δ 7.35 (m, 5H, Ar), 5.61 (s, 1H, CHAr), 5.31 (m, 3H, H-5II, H-3I, H-4II),
5.22–5.17 (m, 2H, H-1II, H-3II), 4.77 (s, 1H, H-1I), 4.32–4.23 (m, 3H, OCH2aCH2CH2S,
H-6aII, H-2I), 4.13–4.02 (m, 3H, H-4I, H-2II, H-6bII), 3.88–3.77 (m, 3H, H-6aI,
OCH2bCH2CH2S, H-5I), 3.52 (td, J6a,6b = 10.05 Hz, J5,6 = 6.11 Hz, 1H, H-6bI), 2.74 (m,
4H, SCH2CH2SH), 2.62 (t, J = 7.0 Hz, 2H, OSCH2CH2CH2S), 2.24 (s, 3H, COCH3), 2.10
(s, 3H, COCH3), 2.07 (s, 3H, COCH3), 2.06 (s, 3H, COCH3), 1.97 (s, 3H, COCH3), 1.88
(m, 2H, OSCH2CH2CH2S), 1.72 (dd, J = 7.87, 7.23 Hz, 1H, SH).

13

C NMR (126 MHz,

CDCl3): δ 170.56, 170.40, 169.90, 169.79, 169.69 (5C, 5 COCH3), 136.94 (Ar), 128.86
(Ar), 128.09 (Ar × 2), 125.91 (Ar × 2), 101.35 (CHAr), 98.72 (C-1II), 98.31 (C-1I), 78.91
(C-4I), 71.14 (C-2I), 70.89 (C-3I), 69.18 (2C, C-5II, C-2II), 68.83 (C-3II), 68.53
(OCH2CH2CH2S), 66.21 (C-6I), 65.65 (C-4II), 63.49 (C-5I), 62.36 (C-6II), 36.21
(SCH2CH2SH), 29.12 (OSCH2CH2CH2S), 28.62 (OCH2CH2CH2S), 24.64 (SCH2CH2SH),
20.80, 20.76, 20.73, 20.70, 20.64 (5C, COCH3). MALDI-TOFMS: calcd for
C34H46O16S2Na [M+Na]+ m/z 797.2125, found m/z 797.2164.
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S-(2-[(3-( [2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→3)-2,4,6-tri-O-acetyl-α-Dmannopyranosyl]oxy)propyl)sulfanyl]ethyl) ethanethioate (23)

Compound 21 (500 mg, 0.645 mmol) was treated with 60% aq HOAc (30 mL) at 70 °C
for 40 min.65 Concentration and azeotropic distillation with toluene afforded a dry residue
that was acetylated following general procedure 1. After concentration, purification by
column chromatography on silica gel afforded 23 (420 mg, 79%) as a colorless oil. [α]D =
+15.4º (c = 1 in CHCl3). 1H NMR (300 MHz, CDCl3): δ 5.23 (m, 4H, H-3I, H-4I, H-2I, H3II), 5.01 (m, 2H, H-2II, H-1II), 4.82 (d, J = 1.40 Hz, 1H, H-1I), 4.25 (m, 4H, H-6aI, H6aII, H-4II, H-6bI), 4.15 (m, 1H, H-5II), 4.07 (m, 1H, H-6bII), 3.85 (m, 2H, H-5I,
OCH2aCH2CH2S), 3.53 (m, 1H, OCH2bCH2CH2S), 3.06 (m, 2H, SCH2CH2S), 2.66 (m,
4H, SCH2CH2S, OCH2CH2CH2S), 2.34 (s, 3H, SCOCH3), 2.20 (s, 3H, OCOCH3), 2.13
(2s, 6H, 2 OCOCH3), 2.10 (s, 6H, 2 OCOCH3), 2.04 (s, 3H, OCOCH3), 1.98 (s, 3H,
OCOCH3), 1.89 (m, 2H, OCH2CH2CH2S).
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C NMR (75 MHz, CDCl3): δ 195.46

(SCOCH3), 170.83, 170.72, 170.54, 170.13, 170.02, 169.95, 169.71 (7C, 7 OCOCH3),
99.13 (C-1I), 97.57 (C-1II) 75.33 (C-3I), 71.07 (C-2I), 70.09 (C-2II), 69.51 (C-5II), 68.94
(C-5I), 68.44 (C-3II), 67.75 (C-4II), 66.53 (OCH2CH2CH2S), 66.03 (C-4I), 62.72 (C-6I),
62.49 (C-6II), 31.89 (SCOCH3), 30.78 (SCH2CH2S) 29.27 (SCH2CH2S), 29.18
(OCH2CH2CH2S), 28.59 (OCH2CH2CH2S), 21.10, 20.98, 20.95, 20.88, 20.82 (5C, 5
95

OCOCH3), 20.78 (2C, OCOCH3). MALDI-TOFMS: calcd for C33H48O19S2Na [M+Na]+
m/z 835.2129; found m/z 835.2156.

3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→3)-α-Dmannopyranoside (23)

Following

the

general

procedure

1,

3-[(2-sulfanylethyl)sulfanyl]propyl

α-D-

mannopyranosyl-(1→3)-α-D-mannopyranoside (24) was synthesized on a 300-mg (0.37
mmol) scale. Yield: 112 mg, 64%. [α]D = +2.38º (c = 1 in MeOH). 1H NMR (500 MHz,
CD3OD): δ 5.08 (1H, H-1II), 4.74 (1H, H-1I), 4.03 (m, 1H, H-2I), 3.98 (d, J = 1.22 Hz,
1H, H-2II), 3.81 (m, 7H, H-3I, H-4I, H-5I, H-6aI, H-6aII, H-5II, OCH2aCH2CH2S), 3.72
(m, 2H, H-6bI, H-6bII), 3.62 (t, J3,4 J4,5 = 9.57 Hz, 1H, H-4II), 3.56 (m, 2H, H-3II,
OCH2bCH2CH2S), 2.92 (m, 2H, SCH2CH2SH), 2.85 (dd, J = 8.83, 5.31 Hz, 2H,
OCH2CH2CH2S), 2.68 (t, J = 7.16, 7.16 Hz, 2H, SCH2CH2SH), 1.89 (m, 2H,
OCH2CH2CH2S).
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C NMR (126 MHz, CD3OD): δ 103.85 (C-1II), 101.69 (C-1I), 80.63

(C-3I), 74.87 (C-3II), 74.86 (C-5I), 72.47 (C-5II), 72.12 (C-2II), 71.48 (C-2I), 68.77 (C-4II),
67.54 (C-4I), 67.02 (OCH2CH2CH2S), 62.84 (C-6II), 62.77 (C-6I), 39.67 (SCH2CH2SH),
32.28 (OCH2CH2CH2S), 30.65 (OCH2CH2CH2S), 29.61 (SCH2CH2SH). MALDITOFMS: calcd for C17H32O11S2Na [M+Na]+ m/z 499.1284; found m/z 499.1297.
96

Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25)

Following the general procedure 4, compound 25 was synthesized on a 1-g (1.57 mmol)
acceptor scale. Yield: 900 mg, 59%. [α]D = +21.3º (c = 1 in CHCl3). 1H NMR (500 MHz,
CDCl3): δ 7.44 (m, 2H, Ar), 7.32 (m, 3H, Ar), 5.88 (m, 1H, OCH2CH=CH2), 5.67 (s, 1H,
CHAr), 5.43 (m, 2H, H-3III, H-5II), 5.30 ( m, 4H, H-4II, H-5III, H-1III, OCH2CH=CH2a),
5.21 (m, 4H, OCH2CH=CH2b, H-3II, H-1II, H-4III), 4.89 (s, 1H, H-1I), 4.27 (m, 3H, H-3I,
H-6aIII, H-6aII), 4.16 (m, 4H, H-6aI, OCH2aCH=CH2, H-4I, H-6bII), 4.08 (m, 3H, H-6bIII,
H-2I, H-2III), 3.99 (m, 2H, OCH2bCH=CH2, H-2II), 3.89 (m, 1H, H-6I), 3.82 (m, 1H, H5I), 2.16 (s, 3H, COCH3), 2.10 (s, 3H, COCH3), 2.06 (m, 9H, 3 COCH3), 2.04 (s, 3H,
COCH3), 2.02 (s, 3H, COCH3), 1.94 (s, 3H, COCH3).

13

C NMR (126 MHz, CDCl3): δ

170.59, 170.51, 169.86, 169.83, 169.80, 169.76, 169.45, 169.29 (8C, 8 COCH3), 137.08
(OCH2CH=CH2), 133.16 (Ar), 128.79 (Ar), 128.08 (Ar × 2), 126.03 (Ar × 2), 118.16
(OCH2CH=CH2), 101.30 (CHAr), 99.48 (C-1II), 98.65 (C-1I), 98.29 (C-1III), 78.87 (C-4I),
77.46 (C-2I), 72.41 (C-3I), 69.35 (C-4II), 69.25 (C-2III), 69.20 (C-5II), 69.09 (C-2II), 68.72
97

(C-3III), 68.54 (C-3II), 68.46 (C-6I), 68.28 (OCH2CH=CH2), 66.45 (C-5III), 66.40 (C-4III),
64.01 (C-5I), 62.70 (C-6II), 62.60 (C-6III), 20.85 (COCH3), 20.72 (2C, 2 COCH3),
20.71(3C, 3 COCH3), 20.68 (COCH3), 20.60 (COCH3). MALDI-TOFMS: calcd for
C44H56O24Na [M+Na]+ m/z 991.3059; found m/z 991.3018.

3-[(2-Sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→2)-[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-Dmannopyranoside (26)

The general procedure 3 was used to synthesize 26 on an 800-mg (0.83 mmol) scale.
Yield: 690 mg, 78%. [α]D = +37.67º (c = 1 in CHCl3). 1H NMR (500 MHz, CDCl3): δ
7.44 (m, 2H, Ar), 7.32 (m, 3H, Ar), 5.67 (s, 1H, CHAr), 5.41 (m, 2H, H-3III, H-5II), 5.32
(m, 1H, H-4II), 5.25 (m, 4H, H-5III, H-1III, H-3II, H-4III), 5.19 (s, 1H, H-1II), 4.85 (s, 1H,
H-1I), 4.26 (m, 4H, H-3I, H-6I, H-6II, H-6III), 4.16 (dd, J = 10.98, 8.28 Hz, 2H, H-6II, H4I), 4.06 (m, 3H, H-2I, H-6III, H-2III), 3.98 (t, 1H, H-2II), 3.88 (t, J = 10.32, 10.32 Hz, 1H,
H-6I), 3.79 (q, 2H, H-5I, OCH2aCH2CH2S), 3.53 (td, J = 9.73, 6.18, 6.18 Hz, 1H,
98

OCH2bCH2CH2S), 2.72 (m, 4H, SCH2CH2SH), 2.61 (t, J = 7.00, 7.00 Hz, 2H,
OCH2CH2CH2S), 2.15, 2.10, 2.08, 2.06, 2.05, 2.03, 2.01, 1.94 (8 s, 24H, 8 COCH3), 1.88
(m, 2H, OCH2CH2CH2S), 1.71 (t, J = 7.82, 7.82 Hz, 1H, SCH2CH2SH). 13C NMR (126
MHz, CDCl3): δ 170.64, 170.62, 169.96, 169.93 (4C, 4 COCH3), 169.92 (2C, 2 COCH3),
169.58, 169.44 (2C, 2 COCH3), 137.20 (Ar), 128.94 (Ar), 128.23 (Ar × 2), 126.18(Ar ×
2), 101.43 (CHAr), 99.63 (C-1I), 99.62 (C-1II), 98.64 (C-1III), 78.82 (C-4I), 77.84 (C-2I),
73.09 (C-3I), 69.49 (C-4II), 69.41 (C-5II), 69.38 (C-2III), 69.15 (C-2II), 68.81 (C-3II), 68.69
(C-3II), 68.63 (C-6I), 66.66 (C-5III), 66.51 (C-4III), 66.34 (OCH2CH2CH2S), 64.20 (C-5I),
62.93 (C-6II), 62.69 (C-6III), 36.37 (SCH2CH2SH), 29.33 (OCH2CH2CH2S), 28.81
(OCH2CH2CH2S), 24.79 (SCH2CH2SH), 20.99 (COCH3), 20.91 (COCH3), 20.87 (2C, 2
COCH3), 20.86 (COCH3), 20.85 (COCH3), 20.81 (COCH3), 20.74 (COCH3). MALDITOFMS: calcd for C46H62O24S2Na [M+Na]+ m/z 1085.2970; found m/z 1085.2979.
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S-(2-[(3-([2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetylα-D-mannopyranosyl-(1→3)]-4,6-di-O-acetyl-α-D-mannopyranosyl]oxy)propyl)sulfanyl]ethyl) ethanethioate (28)

Following general procedure 6, the benzylidene group on 26 (0.60 g, 0.56 mmol) was
removed and the intermediate was acetylated using general procedure 1 to afford
trisaccharide 28. Yield: 392 mg, 82% over two steps. [α]D = +18.7º (c = 1 in CHCl3). 1H
NMR (500 MHz, CDCl3): δ 5.37 (m, 2H, H-3II, H-5II), 5.27 (m, 4H, H-2II, H-4II. H-3III,
H-3I), 5.15 (m, 1H, H-2III), 5.05 (d, J = 1.17 Hz, 1H, H-1I), 5.04 (bd, 1H, H-1II), 4.97 (bd,
1H, H-1III), 4.28 (dd, J = 12.14, 5.80 Hz, 1H, H-6aIII), 4.20 (m, 4H, H-5III, H-6aII, H-6aI,
H-6bII), 4.10 (m, 3H, H-6bI, H-4III, H-4I), 4.02 (m, 2H, H-2I, H-6bIII), 3.81 (m, 2H, H-5I,
OCH2aCH2CH2S), 3.51 (m, 1H, OCH2bCH2CH2S), 3.05 (dd, J = 9.09, 6.59 Hz, 2H,
SCH2CH2S), 2.66 (m, 4H, SCH2CH2S, OCH2CH2CH2S), 2.33 (s, 3H, SCOCH3), 2.15 (s,
3H, OCOCH3), 2.13 (s, 9H, 3 OCOCH3), 2.08 (s, 3H, OCOCH3), 2.06 (s, 3H, OCOCH3),
2.05 (s, 3H, OCOCH3), 2.04 (s, 3H, OCOCH3), 1.98 (s, 3H, OCOCH3), 1.97 (s, 3H,
OCOCH3), 1.89 (m, 2H, OCH2CH2CH2S).
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C NMR (126 MHz, CDCl3): δ 195.47

(SCOCH3), 171.07, 170.58, 170.47, 170.19, 170.12, 169.93, 169.73, 169.65, 169.47,
169.33 (10C, 10 OCOCH3), 99.66 (C-1III), 99.27 (C-1II), 98.11 (C-1I), 78.91 (C-2I), 78.06
(C-4I), 69.77 (C-4II), 69.71 (C-2III), 69.42 (C-5III), 69.34 (C-5I), 69.20 (C-4III), 68.88 (C3III), 68.79 (C-3II), 66.62 (OCH2CH2CH2S), 66.52 (C-5II), 66.05 (C-2II), 62.92 (C-6III),
62.71 (C-6II), 62.39 (C-6I), 31.90 (OCH2CH2CH2S), 30.77 (SCOCH3), 29.26, 29.23,
28.61, 20.98 (4C, 4 OCOCH3), 20.90 (2C, 2 OCOCH3), 20.85 (2C, 2 OCOCH3), 20.84,
20.80, 20.77 (3C, 3 OCOCH3), 20.74 (2C, 2 OCOCH3). MALDI-TOFMS: calcd for
C45H64O27S2Na [M+Na]+ m/z 1123.2974; m/z found 1123.3026.

3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-[α-D-mannopyranosyl-(1→3)]-α-D-mannopyranoside (29)

Acetylated trisaccharide 28 was fully deprotected following general procedure 2 on a
300-mg (0.27 mmol) scale. Yield: 133 mg, 76%. [α]D = +47.5º (c = 1 in MeOH). 1H
NMR (500 MHz, CD3OD): δ 5.10 (d, J1,2 = 1.58 Hz, 1H, H-1III), 5.08 (d, J1,2 = 1.56 Hz,
1H, H-1II), 5.04 (d, J1,2 = 1.56 Hz, 1H, H-1I), 4.03 (dd, J2,3 = 2.85 Hz, J1,2 = 1.59 Hz, 1H,
H-2I), 3.97 (dd, J2,3 = 3.17 Hz, J1,2 = 1.56 Hz, 1H, H-2III), 3.94 (dd, J 3,4 = 9.59 Hz, J2,3 =
101

3.06 Hz, 1H, H-3I), 3.88 (dd, J2,3 = 3.20 Hz, J 1,2 = 1.60 Hz, 1H, H-2II), 3.86 (m, 1H, H6aIII), 3.82 (m, 3H, H-6aII, H-6aI, OCH2aCH2CH2S), 3.69 (m, 9H, H-4I, H-6bI, H-6bII, H3III, H-3II, H-6bIII, H-5III, H-5II, H-4III), 3.56 (m, 3H, H-4II, H-5I, OCH2bCH2CH2S), 2.93
(m, 2H, SCH2CH2SH), 2.85 (m, 2H, SCH2CH2SH), 2.67 (t, J = 7.20, 7.20 Hz, 2H,
OCH2CH2CH2S), 1.89 (m, 2H, (OCH2CH2CH2S).
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C NMR (126 MHz, CD3OD): δ

104.03 (C-1III), 103.45 (C-1II), 100.01 (C-1I), 79.56 (C-2I), 79.45 (C-3I), 75.24 (C-5II),
75.10 (C-3II), 74.95 (C-5I), 72.55 (C-5III), 72.37 (C-3III), 72.10 (C-2II), 72.05 (C-2III),
68.79 (C-4II), 68.73 (C-4III), 68.40 (C-4I), 67.16 (OCH2CH2CH2S), 63.15 (C-6III), 63.00
(C-6II),

62.88

(C-6I),

39.65

(SCH2CH2SH),

32.29

(SCH2CH2SH),

30.70

(OCH2CH2CH2S), 29.64 (OCH2CH2CH2S). MALDI-TOFMS: calcd for C23H42O16S2Na
[M+Na]+ m/z 661.1812; found m/z 661.1789. 93

Propargyl α-D-mannopyranoside (30)

Following the general procedure 2 for deacetylation, compound 30 was synthesized on a
12 g (31 mmol) scale. Yield: 6.02 g (88%). 1H NMR (300 MHz, CD3OD): δ 4.96 (d, J1,2
= 1.6 Hz, 1H, H-1), 4.29–4.23 (m, 2H, OCH2CCH), 3.82 (m, 2H), 3.74–3.56 (m, 3H),
3.54–3.46 (m, 1H), 2.87– 2.82 (m, 1H, OCH2C≡CH).

102

13

C NMR (75 MHz, CD3OD): δ

99.79 (C-1), 80.00, 75.98, 75.05, 72.45, 71.98, 68.42, 62.79, 54.82 (C-6). The
spectroscopic data matched that in literature.94

Propargyl α-D-mannopyranoside (30)95

To a slurry of silica gel (10 g 200–400 mesh) in dry Et2O (50 mL) was added
commercially available concentrated H2SO4 (3 mL) with shaking for 5 min. The solvent
was evaporated under reduced pressure resulting in free flowing H2SO4–silica which was
then dried at 110 ºC for 3 h. A suspension of D-mannose (1.8 g, 10 mmol) in propargyl
alcohol (2.9 mL, 50 mmol) was heated to 65 ºC while stirring. H2SO4–silica (50 mg) was
added and stirring was continued until all the solids had dissolved (2.5 h). At this point,
TLC (5:1 CH2Cl2–MeOH) showed complete conversion of the starting D-mannose to a
faster running component. After cooling to room temperature, the reaction mixture was
transferred to a short silica gel column and the excess propargyl alcohol was eluted with
DCM followed by elution of the product with CH2Cl2–MeOH (15:1) to afford the desired
propargyl glycoside (30) in 65% yield. Spectroscopic data matched that in literature.94
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Propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (31)83

α,β-D-Mannopyranose pentaacetate (3.22 g, 8.24 mmol) and propargyl alcohol (0.77 mL,
13 mmol) were dissolved in 40 mL of dry dichloromethane (DCM). The mixture was
cooled to 0 °C and boron trifluoride etherate (15 mmol, 2.13 g) was added in two
portions. After removal of the cooling bath the reaction was stirred for 24 h.
Subsequently, the mixture was quenched with saturated NaHCO3 solution; the organic
phase was dried over MgSO4 and concentrated. The residue was purified by column
chromatography (2:1 hexane–EtOAc) to give 2.7 g (84 %) of 31 as a colorless solid. 1H
NMR (300 MHz, CDCl3): δ 5.31–5.18 (m, 3H, H-3, H-2, H-4), 4.98 (d, J1,2 = 1.4 Hz, 1H,
H-1), 4.27–4.16 (m, 3H, OCH2C≡CH, H-6a), 4.05 (dd, J6a,6b = 12.2 Hz, J5,6b = 2.4 Hz, 1H,
H-6b), 4.00–3.92 (m, 1H, H-5), 2.46 (t, J = 2.4 Hz, 1H, OCH2C≡CH), 2.12 (s, 3H,
COCH3), 2.03 (s, 3H, COCH3), 1.99 (s, 3H, COCH3), 1.95(s, 3H, COCH3). 13C NMR (75
MHz, CDCl3): δ 170.61, 169.92, 169.82, 169.68 (4C, 4 COCH3), 96.22 (C-1), 77.95
(OCH2C≡CH), 75.69 (OCH2C≡CH), 69.33 (C-5), 68.97 (C-3), 68.92 (C-2), 65.98 (C-4),
62.30 (C-6), 54.94 (OCH2C≡CH), 20.87, 20.75, 20.69, 20.66 (4C, 4 COCH3). The
spectroscopic data matched that previously reported.95
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Propargyl 4,6-O-benzylidene-α-D-mannopyranoside (32)
OH
HO
HO
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Propargyl 4,6-O-benzylidene-α-D-mannopyranoside (32) was synthesized following
similar procedure used for the synthesis of allyl 4,6-O-benzylidene-α-D-mannopyranoside
(7) on a 6.02-g scale (27.6 mmol). Yield: 6.4 g (76%). 1H NMR (300 MHz, CDCl3): δ
7.55–7.31 (m, 5H, Ar), 5.56 (s, 1H, CHAr), 5.06 (s, 1H, H-1), 4.32 – 4.21 (m, 3H), 4.07
(d, J = 10.8 Hz, 2H), 3.98–3.76 (m, 3H), 2.75 (s, 2H, 2 OH), 2.48 (t, J = 2.3 Hz, 1H,
OCH2C≡CH).
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C NMR (75 MHz, CDCl3): δ 137.26, 129.47, 128.52 (Ar × 2), 126.40

(Ar × 2), 102.44 (CHAr), 98.96 (C-1), 78.85, 78.68, 75.20, 70.88, 68.79, 68.70, 63.60,
54.78 (OCH2C≡CH). HRDARTMS: calcd for C16H18O6 [M]+ m/z 306.1103, calcd for
[M+H]+ m/z 307.1182; found m/z 307.1108.

Propargyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (33)

Propargyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (33) was
synthesized following similar procedure used for the synthesis of compound 8 on a 3.5-g
(11.4 mmol) scale. Yield: 3.21 g (65%). 1H NMR (300 MHz, CDCl3): δ 7.50 (m, 2H, Ar),
7.45–7.34 (m, 3H, Ar), 7.28 (m, 2H, Ar), 6.91–6.83 (m, 2H, Ar), 5.62 (s, 1H, CHAr),
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5.06 (d, J1,2 = 1.4 Hz, 1H, H-1), 4.78 (d, J = 11.4 Hz, 1H, OCH2aC≡CH), 4.64 (d, J =
11.4 Hz, 1H, OCH2aC≡CH), 4.26 (m, 3H, OCH2aAr, H-6a), 4.11 (m, 1H, H-5), 4.02 (m,
1H, H-2), 3.91 (dd, J3,4 = 9.5 Hz, J2,3 = 3.5 Hz 1H, H-3), 3.88–3.82 (m, 2H, OCH2bAr, H4), 3.80 (s, 3H, OCH3), 2.85 (bs, 1H, OH), 2.47 (t, J = 2.4 Hz, 1H, OCH2C≡CH).
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C

NMR (75 MHz, CDCl3): δ 159.50, 137.61, 130.10 (Ar × 3), 129.65 (2 × Ar), 129.03 (Ar),
128.30 (2 × Ar), 126.16 (2 × Ar), 113.97 (2 × Ar), 101.69 (CHAr), 98.84 (C-1), 78.76 (C5), 78.70 (OCH2C≡CH), 75.23 (C-3), 75.13 (OCH2C≡CH), 72.87 (OCH2C≡CH), 69.85
(C-2), 68.78 (CH2Ar), 63.87 (C-4), 55.36 (ArOCH3), 54.58 (C-6). HRDARTMS: calcd
for C24H26O7 [M]+ m/z 426.1679; found m/z 426.1572.

Ethyl 2,3,4,6-tetra-O-acetyl-1-thio-α-D-mannopyranoside (34)85

Anhydrous DCM (100 mL) was added to D-mannose pentaacetate (2, 10.5 g, 26.9 mmol)
along with ethanethiol (6.0 mL, 81 mmol). BF3·Et2O (10 mL, 79 mmol) was added and
stirred under an argon atmosphere for 2 h at 0 ºC, followed by 16 h at rt. Saturated
NaHCO3 was added and the solution was stirred for 2 h. The organic layer was dried over
Mg2SO4 and concentrated. The residue was purified by silica gel chromatography using
3:1 toluene–EtOAc as the eluent to afford a white solid (34, 8.1 g, 76%). 1H NMR (300
MHz, CDCl3): δ 5.34–5.25 (m, 4H, H-1, H-2, H-3, H-4), 4.38 (ddd, 1H, J4,5 = 9.9 Hz, J5,6a
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= 5.3 Hz, J5,6b = 2.3 Hz, H-5), 4.29 (dd, 1H, J5,6a = 5.3 Hz, J6a,6b = 12.1 Hz, H-6a), 4.08
(dd, 1H, J5,6b = 2.3 Hz, J6a,6b = 12.1 Hz, H-6b), 2.60–2.66 (m, 2H, SCH2CH3), 2.16 (s, 3H,
COCH3), 2.03 (s, 3H, COCH3), 2.02 (s, 3H, COCH3), 1.97 (s, 3H, COCH3), 1.28 (t, 3H,
SCH2CH3). Spectroscopic data matched that in the literature.85

Propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-4,6-O-benzylidene-αD-mannopyranoside

(35)

Following general procedure 6 for glycosylation, the disaccharide 12 was synthesized on
a 1.20-g (2.81 mmol) acceptor scale. Purification by column chromatography (2:1
hexane–EtOAc) gave 35 as a colorless oil (1.12 g, 61%). [α]D = +31.07º (c = 1 in CHCl3).
1

H NMR (500 MHz, CDCl3): δ 7.54–7.45 (m, 2H, Ar), 7.40–7.30 (m, 3H, Ar), 5.64 (s,

1H, CHAr), 5.44 (dd, J2,3 = 3.4 Hz, J1,2 = 1.8 Hz, 1H, H-2II), 5.38 (dd, J3,4 = 10.0 Hz, J2,3
= 3.4 Hz, 1H, H-3II), 5.29 (t, J3,4 = J4,5 =10.0 Hz, 1H, H-4II), 5.15 (d, J1,2 = 1.6 Hz, 1H, H1II), 5.10 (d, J1,2 = 1.4 Hz, 1H, H-1I), 4.28–4.22 (m, 4H, OCH2C≡CH, H-6aI, H-6aII),
4.18–4.13 (m, 2H, H-6bII, H-3I), 4.11–4.08 (m, 1H, H-5II), 4.07 (dd, J2,3 = 3.4 Hz, J1,2 =
1.6 Hz, 1H, H-2I), 3.93 (t, J3,4 = J4,5 = 9.4 Hz, 1H, H-4I), 3.89–3.79 (m, 2H, H-6bI, H-5I),
2.50 (t, J = 2.4 Hz, 1H, OCH2C≡CH), 2.15 (s, 3H, COCH3), 2.11 (s, 3H, COCH3), 2.07
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(s, 3H, COCH3), 2.01 (s, 3H, COCH3). 13C NMR (126 MHz, CDCl3): δ 170.79, 170.20,
170.00, 169.85 (4C, 4 COCH3), 137.27 (Ar), 129.37 (Ar), 128.47 (Ar × 2), 126.42 (Ar ×
2), 102.29 (CHAr), 99.97 (C-1II), 98.27 (C-1I), 78.90 (C-4I), 78.47 (OCH2C≡CH), 78.19
(C-2I), 75.44 (OCH2C≡CH), 69.30 (C-2II), 69.28 (C-5II), 69.20 (C-3II), 68.84 (C-3I),
68.62 (C-6I), 66.36 (C-4II), 64.19 (C-5I), 62.64 (C-6II), 54.87 (OCH2C≡CH), 21.01, 20.93,
20.86, 20.85 (4C, 4 COCH3). MALDI-TOFMS: calcd for C30H36O15Na [M+Na]+ m/z
659.1952; found m/z 659.1980.

Propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-3-O-acetyl-4,6-Obenzylidene-α-D-mannopyranoside (36)

Propargyl

2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-3-O-acetyl-4,6-O-benzyl-

idene-α-D-mannopyranoside (36) was synthesized from compound 35 (1.03 g, 1.62
mmol) following general procedure 1. Yield: 951 mg, 86%. [α]D = +26.80º (c = 1 in
CHCl3). 1H NMR (500 MHz, CDCl3): δ 7.49–7.43 (m, 2H, Ar), 7.38–7.32 (m, 3H, Ar),
5.61 (s, 1H, CHAr), 5.41 (dd, J3,4 = 10.0 Hz, J2,3 = 3.4 Hz, 1H, H-3II), 5.35–5.25 (m, 3H,
H-4II, H-3I H-2II), 5.09 (d, J1,2 = 1.5 Hz, 1H, H-1II), 4.90 (d, J1,2 = 1.6 Hz, 1H, H-1I),
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4.29– 4.20 (m, 4H, OCH2C≡CH, H-6aI, H-6aII), 4.15 (dt, J = 5.4, 2.7 Hz, 1H), 4.14–4.06
(m, 3H), 3.97–3.90 (m, 1H), 3.87 (dd, J = 12.5, 7.7 Hz, 1H), 2.49 (t, J = 2.4 Hz, 1H,
OCH2C≡CH), 2.15 (s, 3H, COCH3), 2.09 (s, 3H, COCH3), 2.08 (s, 3H, COCH3), 2.06 (s,
3H, COCH3), 2.03 (s, 3H, COCH3).

13

C NMR (125 MHz, CDCl3): δ 170.67, 170.34,

170.08, 169.99, 169.77 (5C, 5 COCH3), 137.23 (Ar), 129.15 (Ar), 128.32 (Ar × 2),
126.31 (Ar × 2), 101.93 (CHAr), 99.81 (C-1II) , 97.96 (C-1I), 78.28 (OCH2C≡CH), 77.53,
76.01, 75.56, 69.72, 69.59, 69.30, 68.81, 68.56, 66.31, 64.46, 62.46, 54.84 (OCH2C≡CH),
20.94, 20.88, 20.86, 20.81, 20.79 (5C, 5 COCH3). MALDI-TOFMS: calcd for
C32H38O16Na [M+Na]+: m/z 701.2058; found m/z 701.2123.

Propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-3,4,6-tri-O-acetyl-αD-mannopyranoside

(37)

The benzylidene group of foregoing compound 36 (880 mg, 1.25 mmol) was removed
following general procedure 6. The resulting product was concentrated and acetylated
following general procedure 1 for easier purification and characterization. After
concentration, purification by column chromatography (2:1 hexane–EtOAc) on silica gel
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afforded

propargyl

2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-3,4,6-tri-O-

acetyl-α-D-mannopyranoside (37, 620 mg, 73%) as a colorless oil. [α]D = +37.06º (c = 1
in CHCl3). 1H NMR (300 MHz, CDCl3): δ 5.4–5.33 (m, 2H), 5.34–5.24 (m, 4H), 5.15 (d,
J1,2 = 1.6 Hz, 1H, H-1), 4.93 (d, J1,2 = 1.6 Hz, 1H, H-1), 4.28–4.05 (m, 7H), 3.95 (ddd, J4,5
= 9.5 Hz, J5,6a = 4.2 Hz, J5,6b = 2.4 Hz, 1H, H-5), 2.48 (t, J = 2.4 Hz, 1H, OCH2C≡CH),
2.15 (s, 3H, COCH3), 2.14 (s, 3H, COCH3), 2.09 (s, 3H, COCH3), 2.07 (s, 3H, COCH3),
2.03 (s, 3H, COCH3), 2.02 (s, 3H, COCH3), 2.00 (s, 3H, COCH3).

13

C NMR (75 MHz,

CDCl3): δ 171.02, 170.70, 170.48, 169.99, 169.85, 169.60, 169.48 (7C, 7 COCH3), 99.31
(C-1), 97.01 (C-1), 78.21 (OCH2C≡CH), 76.87, 75.68 (OCH2C≡CH), 70.16, 69.86,
69.34, 69.19, 68.51, 66.40, 66.17, 62.45, 62.13, 55.12 (OCH2C≡CH), 21.02, 20.88, 20.85,
20.81, 20.80 (5C, 5 COCH3), 20.79 (2C, 2 COCH3). MALDI-TOFMS: calcd for
C29H38O18Na [M+Na]+ m/z 697.1956; found m/z 697.2001.

Propargyl α-D-mannopyranosyl-(1→2)-α-D-mannopyranoside (38)

Following

the

general

procedure

1,

propargyl

2,3,4,6-tetra-O-acetyl-α-D-

mannopyranosyl)-(1→2)-3,4,6-tri-O-acetyl-α-D-mannopyranoside (38) was synthesized
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on a 600-mg (0.889 mmol) scale. Yield: 201 mg, 59%. [α]D = +50.4º (c = 1 in MeOH).
1

H NMR (500 MHz, CD3OD): δ 5.20 (d, J1,2 = 1.6 Hz, 1H, H-1), 4.98 (d, J1,2 = 1.8 Hz,

1H, H-1), 4.31–4.20 (m, 2H, OCH2C≡CH), 3.98 (dd, J2,3 = 3.2 Hz, J1,2 = 1.8 Hz, 1H, H2), 3.86–3.77 (m, 4H), 3.74–3.59 (m, 6H), 3.53–3.48 (m, 1H), 2.84 (t, J = 2.4 Hz, 1H,
OCH2C≡CH).

13

C NMR (126 MHz, CDCl3): δ 104.27 (C-1), 98.71 (C-1), 80.29, 80.12,

75.96, 75.12, 74.92, 72.44, 72.05, 71.88, 68.84, 68.56, 62.89 (C-6), 62.85 (C-6), 55.16
(OCH2C≡CH). MALDI-TOFMS: calcd for C15H24O11Na [M+Na]+ m/z 403.1216; found
m/z 403.1287.

Propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetylα-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (39)

Following the general procedure 6, compound 39 was synthesized on a 1.03-g (1.62
mmol) acceptor scale. Yield: 761 mg, 49%. [α]D = +28.23º (c = 1 in CHCl3). 1H NMR
(500 MHz, CDCl3): δ 7.41 (m, 2.9 Hz, 2H, Ar), 7.34–7.28 (m, 3H, Ar), 5.65 (s, 1H,
CHAr), 5.44–5.39 (m, 2H, H-5II, H-4III), 5.33–5.27 (m, 2H, H-2II, H-3III), 5.26 (d, J1,2 =
1.7 Hz, 1H, H-1III), 5.22–5.14 (m, 3H, H-2III, H-1II, H-2I), 5.04 (d, J1,2 = 1.5 Hz, 1H, H111

1I), 4.30–4.21 (m, 6H, H-4II, H-6a,bII, H-6aI, OCH2C≡CH), 4.20–4.12 (m, 2H, H-4I, H6aIII), 4.10–4.03 (m, 3H, H-6bIII, H-3II, H-5I), 3.95 (ddd, J4,5 = 8.8 Hz, J5,6a = 6.3 Hz, J5,6b
= 2.2 Hz, 1H, H-5III), 3.87 (m, 1H, H-6bI), 3.81 (dd, J3,4 = 9.2 Hz, J2,3 = 4.5 Hz, 1H, H-3I),
2.48 (t, J = 2.4 Hz, 1H, OCH2C≡CH), 2.14 (s, 3H, COCH3), 2.10 (s, 3H, COCH3), 2.07
(s, 3H, COCH3), 2.05 (s, 3H, COCH3), 2.04 (s, 3H, COCH3), 2.02 (s, 3H, COCH3), 2.00
(s, 3H, COCH3), 1.92 (s, 3H, COCH3). 13C NMR (126 MHz, CDCl3): δ 170.66, 170.65,
169.94, 169.90, 169.87, 169.82, 169.52, 169.36 (8C, 8 COCH3), 137.11 (Ar), 128.89
(Ar), 128.16 (Ar × 2), 126.11 (Ar × 2), 101.40 (CHAr), 99.60 (C-1II), 98.39 (C-1III),
98.13 (C-1I), 78.72 (C-4I), 78.23 (OCH2C≡CH), 77.25 (C-3III), 75.53 (OCH2C≡CH),
72.31 (C-4II), 69.40 (C-2II), 69.26 (2C, C-4III, C-5I), 69.23 (C-5III), 68.80 (C-5II), 68.62
(C-2III), 68.38 (C-6I), 66.45 (C-3III), 64.49 (C-3I), 62.66 (C-6II), 62.60 (C-6III), 54.67
(OCH2C≡CH), 20.92 (COCH3), 20.84 (COCH3), 20.80 (2C, 2 COCH3), 20.78 (2C, 2
COCH3), 20.75 (COCH3), 20.67 (COCH3). MALDI-TOFMS: calcd for C44H56O24Na
[M+Na]+ m/z 989.2903; found m/z 989.2720.
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Propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetylα-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41)

Following general procedure 7, the benzylidene group on compound 39 (612 mg, 0.632
mmol) was removed to afford an intermediate diol that was acetylated using general
procedure 1 to afford trisaccharide 41. Yield: 433 mg, 71% over two steps. [α]D =
+33.33º (c = 1 in CHCl3). 1H NMR (500 MHz, CDCl3): δ 5.42–5.33 (m, 2H), 5.32–5.18
(m, 5H), 5.12 (m, 1H, H-2), 5.08 (d, J1,2 = 1.6 Hz, 1H, H-1), 4.96 (d, J1,2 = 1.4 Hz, 1H, H1), 4.30–4.14 (m, 7H), 4.13–4.00 (m, 5H), 3.84 (ddd, J = 10.01, 3.87, 2.45 Hz, 1H), 2.47
(t, J = 2.4 Hz, 1H, OCH2C≡CH), 2.14 (s, 3H, COCH3), 2.12 (s, 3H, COCH3), 2.11 (s, 3H,
COCH3), 2.10 (s, 3H, COCH3), 2.08 (s, 3H, COCH3), 2.06 (s, 2H, COCH3), 2.04 (s, 3H,
COCH3), 2.03 (s, 3H, COCH3), 1.98 (s, 3H, COCH3), 1.96 (s, 3H, COCH3).

13

C NMR

(126 MHz, CDCl3): δ 171.03, 170.61, 170.50, 170.15, 170.10, 169.87, 169.70, 169.55,
169.39, 169.31 (10C, COCH3), 99.47 (C-1), 99.34 (C-1), 96.78 (C-1), 78.48, 78.23
(OCH2C≡CH), 77.36, 75.71 (OCH2C≡CH), 69.76 (2C), 69.63, 69.46, 69.35, 68.73,
68.71, 66.69, 66.46, 66.21, 62.95, 62.50, 62.22, 55.07 (OCH2C≡CH), 20.95, 20.90, 20.85,
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20.85, 20.82, 20.80, 20.78, 20.74, 20.72, 20.69 (10C, 10 COCH3). MALDI-TOFMS:
calcd for C41H54O26Na [M+Na]+ m/z 985.2801; m/z found 985.2695.

Propargyl α-D-mannopyranosyl-(1→2)-[α-D-mannopyranosyl-(1→3)]-α-Dmannopyranoside (42)

Global deprotection of acetylated trisaccharide 41 was achieved following the general
procedure 2 on a 316 mg (0.328 mmol) scale. Yield: 143 mg, 80%. [α]D = +57.52º (c = 1
in MeOH). 1H NMR (500 MHz, CD3OD): δ 5.19 (d, J1,2 = 1.7 Hz, 1H, H-1), 5.09 (m, 2H,
H-1, H-1), 4.32–4.22 (m, 2H, OCH2C≡CH), 4.05 (dd, J2,3 = 3.1 Hz, J1,2 = 1.8 Hz, 1H, H2), 3.97 (dd, J2,3 = 3.2 Hz, J1,2 = 1.8 Hz, 1H, H-2), 3.93 (dd, J3,4 = 9.6 Hz, J2,3 = 3.1 Hz,
1H, H-3), 3.89 (dd, J2,3 = 3.2 Hz, J1,2 = 1.8 Hz, 1H, H-3), 3.87–3.80 (m, 3H), 3.78–3.62
(m, 10H), 3.57–3.52 (m, 1H), 2.85 (t, J = 2.4 Hz, 1H, OCH2C≡CH). 13C NMR (126 MHz,
CD3OD): δ 104.10 (C-1), 103.52 (C-1), 98.71 (C-1), 80.03, 79.46, 79.19, 76.12, 75.35,
75.30, 75.03, 72.52, 72.37, 72.07, 72.01, 68.73, 68.55, 68.25, 62.97, 62.89, 62.72, 55.18
(OCH2C≡CH). MALDI-TOFMS: calcd for C21H34O16Na [M+Na]+ m/z 565.1745; found
m/z 565.1801.
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2-[2-(Benzyloxy)ethoxy]ethanol (45)88

To a mixture of diethylene glycol (43, 4.50 mL, 47.1 mmol) in CH2Cl2 (10 mL) was
added Ag2O (16.3 g, 70.7 mmol) and BnBr (6.15 mL, 51.7 mmol). The solution was
stirred at room temperature for 14 h and filtered through a silica gel pad. The mixture was
concentrated and flash column chromatography (1:1 hexane–EtOAc) gave pure 45 as a
colorless oil (7.65 g, 83%). 1H NMR (300 MHz, CDCl3): δ 7.39–7.23 (m, 5H, Ar), 4.55
(s, 2H, CH2Ar), 3.73–3.64 (m, 4H. OCH2CH2O), 3.63–3.55 (m, 4H, OCH2CH2O), 3.04
(t, J = 6.0 Hz, 1H, OH).

13

C NMR (75 MHz, CDCl3): δ 137.81 (Ar), 128.29 (Ar × 2),

127.69 (Ar × 2), 127.59 (Ar), 73.11 (CH2Ar), 72.46 (OCH2CH2OBn), 70.21
(HOCH2CH2O), 69.27 (OCH2CH2OBn), 61.46 (HOCH2CH2O). Spectroscopic data
matched that previously reported.88

2-[2-(Benzyloxy)ethoxy]ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (46)

To a mixture of compound 45 (1.0 g, 5.1 mmol) and trichloroacetimidate donor 12 (3.7 g,
7.6 mmol) in CH2Cl2 (10 mL) was added powdered 4-Å molecular sieves (300 mg), and
the mixture stirred at room temperature for 30 min under an N2 atmosphere. The solution
was cooled to -30 ºC and TMSOTf (92 µL, 0.51 mmol) was added. After TLC showed
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total consumption of the acceptor, Et3N (1 mL) was added to quench the reaction. The
mixture was diluted with CH2Cl2, filtered over a pad of Celite and concentrated. Column
chromatography on silica gel (1:1 hexane–EtOAc) afforded pure 46 as a slightly brown
oil (1.05 g, 39%). [α]D = +33.53 º (c = 1.0, CHCl3). 1H NMR (300 MHz, CDCl3): δ 7.42–
7.28 (m, 5H, Ar), 5.37 (m, 1H, H-3), 5.29 (m, 2H, H-4, H-2), 4.89 (d, J = 1.7 Hz, 1H, H1), 4.56 (m, 2H, CH2Ar), 4.31 (dd, J6a,6b = 12.8 Hz, J5,6 = 5.4 Hz, 1H, H-6a), 4.15–4.05
(m, 2H, H-5, H-6b), 3.91–3.77 (m, 1H, CHOCH2aCH2O), 3.72–3.66 (m, 5H,
CHOCH2bCH2O, OCH2CH2OBn, CHOCH2CH2O), 3.65–3.60 (m, 2H, OCH2CH2OBn),
2.15 (s, 3H, COCH3), 2.11 (s, 3H, COCH3), 2.01 (s, 3H, COCH3), 2.00 (s, 3H, COCH3).
13

C NMR (75 MHz, CDCl3): δ 170.80, 170.14, 169.99, 169.83 (4C, 4 COCH3), 138.24

(Ar), 128.46 (Ar × 2), 127.81 (Ar × 2), 127.69 (Ar), 97.78 (C-1), 73.32 (CH2Ar), 70.85
(OCH2CH2OBn), 70.10 (CHOCH2CH2O), 69.61 (C-2), 69.48 (OCH2CH2OBn), 69.15 (C3), 68.41 (C-5), 67.48 (CHOCH2CH2O), 66.12 (C-4), 62.44 (C-6), 21.02, 20.88, 20.81,
20.79 (4C, 4 COCH3). MALDI-TOFMS: calcd for C25H34O12Na [M+Na],+ m/z 549.1948;
found m/z 549.1961.
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2-(2-Hydroxyethoxy)ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (47)89

The monosaccharide 46 (800 mg, 1.52 mmol) was dissolved in 1:1 EtOAc–EtOH (120
mL) and 20% Pd(OH)2 (80 mg) was added. The mixture was stirred for 8 h under an H2
atmosphere. Upon completion of reaction, the catalyst was separated by filtration through
a short pad of Celite. The filtrate was concentrated and purified by column
chromatography on silica gel (2:2:1 hexane–EtOAc–DCM) to give 47 as a colorless oil
(530 mg, 80%). [α]D = +5.33 º (c = 1.0, CHCl3). 1H NMR (300 MHz, CDCl3): δ 5.31 (dd,
J3,4 = 10.0 Hz, J2,3 = 3.4 Hz, 1H, H-3), 5.27–5.16 (m, 2H, H-4, H-2), 4.86 (d, J1,2 = 1.6
Hz, 1H, H-1), 4.21 (dd, J6a,6b = 12.3 Hz, J5,6a = 5.5 Hz, 1H, H-6a), 4.10–3.98 (m, 2H, H-5,
H-6b),

3.79–3.57

(m,

7H,

CHOCH2CH2O,

CHOCH2CH2O,

OCH2CH2OH,

OCH2CH2OH), 3.56–3.50 (m, 2H, OCH2CH2OH), 2.10 (s, 3H, COCH3), 2.04 (s, 3H,
COCH3), 1.98 (s, 3H, COCH3), 1.94 (s, 3H, COCH3).

13

C NMR (75 MHz, CDCl3): δ

170.95, 170.38, 170.12, 169.95 (4C, 4 COCH3), 97.67 (C-1), 72.80 (CHOCH2CH2O),
70.25 (OCH2CH2OH), 69.82 (C-2), 69.06 (C-3), 68.50 (C-5), 67.39 (CHOCH2CH2O),
66.38 (C-4), 62.74 (C-6), 61.98 (OCH2CH2OH), 21.09, 20.93, 20.88, 20.87 (4C, 4
COCH3). HRDARTMS: calcd for C18H28O12Na [M+Na]+ m/z 459.1478, found m/z
459.1520.
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2-(2-[(2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl)oxy]ethoxy)ethyl 2,3,4,6-tetra-Oacetyl-(1→1)-α-D-mannopyranoside (44)

To a mixture of compound 47 (500 mg, 1.15 mmol) and donor 12 (1.13 g, 2.30 mmol) in
CH2Cl2 (13 mL) was added powdered 4-Å molecular sieves (500 mg), and the mixture
was stirred at room temperature for 30 min under an N2 atmosphere. The solution was
cooled to -30 ºC and TMSOTf (20 µL, 0.11 mmol) was added. After stirring for 2 h, Et3N
(0.3 mL) was added to quench the reaction. The mixture was diluted with CH2Cl2,
filtered over a pad of Celite and concentrated. Column chromatography on silica gel (1:2
hexane–EtOAc) afforded pure 44 as a clear oil (358 mg, 41%). [α]D = +20.57 º (c = 1.0,
CHCl3). 1H NMR (600 MHz, CDCl3): δ 5.32 (dd, J3,4 = 10.0 Hz, J2,3 = 3.4 Hz, 1H, H-3),
5.29–5.22 (m, 2H, H-4, H-2), 4.85 (d, J1,2 = 1.56 Hz, 1H, H-1), 4.26 (dd, J6a,6b = 12.3 Hz,
J5,6 = 5.1 Hz, 1H, H-6a), 4.11–4.05 (m, 1H, H-6b), 4.04–3.97 (m, 1H, H-5), 3.82–3.75
(m, 1H, CHOCH2aCH2O), 3.69–3.61 (m, 3H, CHOCH2bCH2O, CHOCH2CH2O), 2.14,
2.07, 2.01, 1.97 (4s, 12H, 4 COCH3).

13

C NMR (75 MHz, CDCl3): δ 170.77, 170.10,

169.99, 169.84 (4C, 4 COCH3), 97.86 (C-1), 70.24 (CHOCH2CH2O), 69.57 (C-2), 69.11
(C-3), 68.50 (C-5), 67.52 (CHOCH2CH2O), 66.17 (C-4), 62.46 (C-6), 21.00, 20.87,
20.81, 20.80 (4C, 4 COCH3). MALDI-TOFMS: calcd for C32H46O21Na [M+Na],+ m/z
789.2493; found m/z 789.2521.
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2-[2-(α-D-Mannopyranosyloxy)ethoxy]ethyl-(1→1)-α-D-mannopyranoside (48)

Following the general procedure 1, the deacetylated disaccharide 48 was synthesized on a
300 mg (0.39 mmol) scale. Purification on LH-20 Sephadex column with H2O and
MeOH as eluents gave 124 mg (74%) of 48 as a colorless oil. [α]D = +26.57 º (c = 1.0,
CHCl3). 1H NMR (300 MHz, CD3OD): δ 4.77 (d, J1,2 = 1.6 Hz, 1H, H-1), 3.84–3.75 (m,
3H, H-3, H-4, H-2), 3.71–3.59 (m, 4H, H-6a, H-6b, CHOCH2CH2O), 3.57–3.51 (m, 2H,
CHOCH2CH2O). 13C NMR (75 MHz, CD3OD): δ 101.71 (C-1), 74.64 (C-5), 72.47 (C-3),
72.09 (C-2), 71.42 (CHOCH2CH2O), 68.60 (C-4), 67.67 (CHOCH2CH2O), 62.92 (C-6).
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PART TWO
PRELIMINARY MICROARRAY ANALYSIS OF INTERACTIONS BETWEEN
MANNOSE DERIVATIVES AND CONCANAVALIN A
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VI. Carbohydrate–Protein Binding Studies
1. Characterization of carbohydrate–protein interactions
Carbohydrate–protein interactions play a central role in a wide range of biological
processes such as cell–cell recognition, viral and bacterial pathogenesis, and
inflammation.96 An understanding of carbohydrate–protein interactions at the molecular
level would lead to better insight into biological processes of living systems and assist in
the development of therapeutic and diagnostic strategies.59 Despite the ubiquity and
importance of carbohydrates in biology, difficulties in the study of carbohydrate–protein
interactions have hindered the development of a mechanistic understanding of
carbohydrate structure and function.59
Investigation of carbohydrate–protein interactions can be approached from two
angles. One is from the side of the proteins, for which currently available molecular
biological approaches are extremely useful. For instance, a carbohydrate–binding protein
can be cloned and overexpressed, so that it can be crystallized for X-ray crystallographic
studies. Site-directed mutagenesis can provide mutants, which are valuable for
understanding the mode of interaction between carbohydrates and lectins.97 In the other
approach, which mostly depends on synthetic organic chemistry, carbohydrates are
manipulated to bring about structural changes that facilitate the understanding of binding
specificity and other fundamental properties of carbohydrate–protein interactions.98
However, the structural complexity of carbohydrates is a major obstacle, and the
binding affinities are typically weak. Different techniques have been used to characterize
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carbohydrate–protein interactions. One common method involves measuring the binding
of lectins to cells, tissues and glycoproteins.32 This approach frequently uncovers
interesting and useful binding properties; however, cells, tissues, and glycoproteins
display complex mixtures of carbohydrate epitopes. Therefore, it is exceedingly difficult
to determine the specific carbohydrate structures being recognized by a particular lectin.
An alternative approach involves measuring binding to structurally defined carbohydrate
epitopes through techniques such as isothermal titration calorimetry (ITC), mono- and
oligosaccharide inhibition studies, enzyme-linked lectin assays (ELLA) and surface
plasmon resonance assays (SPR). Unfortunately, these methods can be labor intensive,
require large amounts of carbohydrates, and/or can be difficult to perform in a highthoughput fashion.96 Moreover, these studies have typically been limited to the small
number of carbohydrate epitopes that were readily available. Another disadvantage with
these methods is that they do not use platforms that can mimic the cell surface, and
therefore do not take advantage of multivalency.
For the enthalpy gain during receptor–ligand complexation, a number of criteria
must be taken into account, such as dipole–dipole interactions, dispersive forces (London
forces), and specific forces such as hydrogen bonding. In aqueous solution, however, the
loss of favorable interactions of both ligand and receptor with solvent has to be
overcompensated in the binding event because the binding of two solutes necessarily
involves the loss of favorable interactions with the solvent. Consequently, binding is
largely driven by hydrophobic effects. This and the quite shallow binding sites of lectins
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account for the weak binding affinities found in carbohydrate recognition. The
presentation of carbohydrates in an array provides a method to simultaneously monitor
multiple binding events and the effects of multivalency (discussed in part one) which
increases binding affinities.

1.1. Carbohydrate Microarrays
Microarrays are miniaturized assemblies of molecules organized across a planar
surface.99 Microarray technologies are novel tools emerging at the frontier of glycomics
that are revolutionizing studies of carbohydrate–protein interactions and the elucidation
of carbohydrate ligands involved not only in endogenous receptor systems but also
pathogen–host interactions.100 Array technology is particularly important in glycomics
because it can dramatically increase the output of biochemical data, and glycoarrays
(arrays displaying carbohydrates) have found several applications (Figure 19).101

Figure 19. Current applications for glycoarrays.101
Analogous to DNA and protein arrays, carbohydrate microarrays contain
numerous carbohydrate epitopes immobilized on a solid support in a miniaturized
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fashion. Glycans attached to surfaces resemble those on cell surfaces, and consequently,
they may interact with proteins in a similar way to that when they are located on cell
surfaces.102 The microarray format allows one to rapidly evaluate many potential
interactions with a minimum amount of sample.96 Not only do arrays shorten the time for
biochemical measurements, but glycoarrays also have the advantage of using less
precious carbohydrate material because of the option of miniaturization that is not
possible in solution studies.101 Another advantage of glycan microarray analysis is the
high detection sensitivity. This is attributed to the fact that the binding of a molecule in
the solution phase to an immobilized microspot of ligand in the solid phase has minimal
reduction of the molar concentration of the molecule in solution.103 Therefore, in a
microarray assay it is much easier to have a binding equilibrium take place and result in a
high sensitivity.1
Generally,

carbohydrate

microarray

methods

fall

into

two

categories:

polysaccharide and oligosaccharide microarrays. Polysaccharides from natural sources
can be readily and randomly immobilized on solid matrices based on hydrophobic
physical absorption104,105 or charge-based interaction106 to generate polysaccharide
microarrays that are valuable for comparable antigenicity analyses.100 On the other hand,
oligosaccharide

microarrays provide detailed

information

on

structure–activity

relationships in carbohydrate recognition events. The immobilization of oligosaccharides
is, however, more challenging due to their hydrophilic nature, and chemical
derivatization procedures are normally required before arraying.
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Various immobilization strategies have been developed to fabricate carbohydrate
microarrays. These can be divided into two main classes, depending on the type of sugar
immobilization: by covalent attachment or by physical adsorption. Stable carbohydrate
microarrays should be fabricated by covalent immobilization, which can be achieved by
Michael addition,107 Diels–Alder reaction,108 Staudinger ligation,109 click chemistry,110
Schiff base formation,111,112 and amide bond formation.113 Although covalent
immobilization offers very stable arrays, the main drawback of this strategy is the need
for the chemical modification of the sugar to introduce a linker, thus allowing its reaction
with the surface.101 This modification is usually done by chemical manipulation,
requiring complex multistep protection–glycosylation–deprotection sequences, with the
need for often difficult purification. While this might not appear to be a major limitation,
in the case of ‘‘simple’’ sugars (monosaccharides), it is a major challenge for glycoarrays
of complex natural oligosaccharides as these are often available in tiny quantities (see
Part One of this dissertation for the synthesis of sugars).100,101
Our approach for this project will utilize covalent immobilization of thiolterminated sugars onto epoxide-functionalized glass slides. This will afford very stable
glycan microarrays for interrogation with proteins.

2. Results and Discussion
Previously, Medhanit Bahta of our group, in collaboration with Dr. Robert Standaert of
the Oak Ridge National Laboratory, assessed the binding activities of self-assembled
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monolayers of some carbohydrates with human serum mannose-binding lectins.75 The
carbohydrates used included a thiol-terminated monosaccharide (previously synthesized
by Brian Sanders) and a Kamerling-derivatized 1,3-α-D-mannobiose. The approach used
was similar to that developed by Mrksich and co-workers, whereby maleimidefunctionalized glass surfaces were arrayed with thiol-terminated mannose derivatives and
incubated with mannose-binding lectins.108 Although the overall avidities of mannosebinding lectins were determined, the binding constants were not.
Herein, we describe the utility of microarray analysis for characterizing
carbohydrate–protein interactions and the determination of dissociation constants.
Microarray detection is invaluable as it allows for the simultaneous analysis of binding
under numerous conditions on a single slide. Synthesized mannose derivatives were
printed on epoxide-functionalized glass slides. On a single glass slide, 12 different
concentrations (0, 25, 50,100, 150, 200, 250, 300, 400, 500, 750, 1000 µM) of each sugar
were probed with 6 different concentrations of protein Con A (2, 5, 10, 20, 30, 50 µg/mL,
which corresponds to 19, 48, 96, 192, 288 and 481 nM, respectively). The sugars selected
for the preliminary studies included the thiol-terminated mannose derivatives shown in
Figure 20. (The synthesis of these compounds can be found in Part One of this
dissertation.)
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Figure 20. Thiol-terminated mannose derivatives 5, 18, and 29 used in
binding studies.

These sugars were selected since they have been derivatized with thiols and will
readily react with epoxide-functionalized glass slides to form covalent bonds when
immobilized. Also, these sugars have hydrophobic aglycons that have been reported to
promote the recognition of sugars by lectins.114 These hydrophobic aglycons may be a
reason for the favorable change in entropy or favorable interactions within the binding
site of Con A. The thiol-terminated sugars are deprotonated in a basic print buffer (PBS,
pH 8.5), and the resultant anion cleaves open the epoxides on the glass surface, hence
forming covalent bonds (Figure 21).
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Figure 21. Covalent bond formation between a tethered sugar and the glass
surface.

Using robotic printing technology, thiol-terminated mannose derivatives 5, 18 and
29 were printed onto epoxide-functionalized glass slides (Figure 22) to achieve covalent
immobilization. The pin on the robotic printer has a 0.25 µL sample channel and a tip
size of 75 µm. It prints sugar spots of ~100 µm in diameter. Initial immobilization of
thiol-terminated sugars was not very successful based on results obtained after protein

128

incubation. This could be attributed to the oxidation of thiol terminals of the sugars when
exposed to air.

Con A

Con A

Figure 22. Top: Picture of a pin-printer. Bottom: Carbohydrate microarray
fabrication and analysis on glass slides
Thiols have a tendency to oxidize and form disulfide bonds when exposed to air
(Scheme 35). It was observed that formation of covalent bonds between sugars and the
epoxide-derivatized surface was minimal when the sugars oxidized and became linked by
disulfide

bonds.

Therefore,

the

reducing

agent

tris(2-carboxyethyl)phosphine

hydrochloride (TCEP.HCl) was added to sugar solutions to cleave the disulfide bonds to
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Scheme 35. Disulfide bond formation.

thiols before printing. The results showed better immobilization of sugars onto the glass
surface with the addition of TCEP. After overnight incubation, the microarrays were
thoroughly washed with wash buffer (PBS, pH 7.4 containing 0.05% Tween-20) to
remove unbound carbohydrate. To prevent a non-specific reaction between the glass
surface and protein, it was necessary to block the unreacted epoxide functional groups on
the glass surface. Initial blocking with Superblock® solution was not very successful, as
this showed too much background fluorescence as a result of the reaction between the
protein and the epoxides. Ethanolamine block buffer showed better results and was used
for all subsequent assays. After blocking for 1 h, the slides were washed and dried, and
the supergrids were mapped out using a permanent-ink marker. Carbohydrate
microarrays were incubated with fluorescent-tagged lectin (lissamine rhodamine-tagged
Concanavalin A) for 1 h at room temperature. After protein incubation, the slides were
washed to remove unbound protein, followed by detection of bound protein through
fluorescence slide scanning.
A representative example of a fluorescence scan resulting from our microarray
studies is depicted in Figure 22. In this analysis, sugars 5, 18 and 29 were printed at 12
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different concentrations ranging from 0–1000 µM (right to left) in 12 × 10 print patterns,
which resulted in three separate grids that make up a supergrid. Each supergrid allows for
the detection of protein binding as a function of the concentration of carbohydrate printed
on the surface. In order to further study the effects of changing protein concentration, six
supergrids were printed and subjected to six different concentrations of Con A. As
depicted in the slide scan in Figure 21, each of the six supergrids (A, B, C, D, E, and F)
was probed using a different concentration of lissamine rhodamine-tagged Con A ranging
from 2–50 µg/mL. After incubation and thorough washing, the glass slides were scanned
to obtain fluorescence intensities (Figure 21).

5

18
A

D

29
B

C

E

F

Figure 23. Scanned image of glycan microarray with Con A. Monosaccharide
5, disaccharide 18 and trisaccharide 29. Protein concentrations: 50 µg/mL (A), 30
µg/mL (B), 20 µg/mL (C), 10 µg/mL (D), 5 µg/mL (E) and 2 µg/mL (F).
D

E
F
To evaluate protein−surface binding, plots of fluorescence intensity versus both

carbohydrate and protein concentration were constructed. The curves were treated as
1
2
3
Langmuir isotherms assuming equilibrium was reached during incubation. The Langmuir
isotherm relates the adsorption of proteins to the immobilized sugars on surface of glass
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slide to the concentration of the protein solution (see Langmuir equation in section 4.2.3).
In these studies, (1→2)-linked disaccharide 18 reproducibly showed the greatest
fluorescence intensities, indicating enhanced binding with Con A (Figure 24). The
trisaccharide 29 showed the least fluorescence intensities and hence was the weakest
ligand for Con A. These results have important implications for understanding complex
cell-surface glycan recognition by validating our hypothesis that sugars are recognized
based on specific patterns of geometric presentation. The steric bulk of the trisaccharide
29 might have contributed to the poor binding to Con A that has a shallow binding
pocket.

400
350
300
F/1000

250
Trisaccharide
200
Disaccharide

150
100
50
0
0

200

400

600

800

1000

[sugars]

Figure 24. Binding curves for three sugars 5, 18 and 29 with Con A at a
concentration of 50 µg/mL.
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Although the printed concentrations of the disaccharide 18 varied by up to 40-fold
from 25 to 1000 µM, the dissociation constants (KD,surf) were narrowly distributed with an
average of 61 nM (SD = 7 nM) from nine replicate experiments. The differences in
dissociation constants seem to be greater at higher concentrations above 400 µM. The
monosaccharide 5 had an average surface dissociation constant of 76 nM (SD = 5 nM),
which is close to that reported in the literature (83 nM for the interaction of Con A and
100 µM mannose monosaccharide).59 The trisaccharide 29 showed less binding than the
other sugars 5 and 18 with a dissociation constant of 91 nM (SD = 4 nM). Generally, as
the concentration of the sugars increased the fluorescence intensities observed increased,
indicating that more protein was adsorbed to the surface. However, this was not
necessarily the case when the protein concentrations were increased (Figure 25).
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Figure 25. Binding curve for disaccharide 18 and Con A using different
concentrations as shown. Errors not shown. Average deviation is ± 28 to that of
Figure 24.

Binding curves for monosaccharide 5 and trisaccharide 29 also showed the same
irregular change in fluorescence as the protein concentrations were increased (Figure 26).
For the monosaccharide 5, there was increased binding as the protein concentration
increased from 2 to 10 µg/mL, but a decrease was observed at a protein concentration of
20 µg/mL. There was an increase in binding observed again at protein concentration of
30 µg/mL and a small decrease at 50 µg/mL. For the trisaccharide 29, there was a steady
increase in binding from a protein concentration of 2–30 µg/mL. However, there was a
small decrease in binding at 40 µg/mL and no noticeable increase at 50 µg/mL. This
might be attributed to the difference in surface coverage of each spot on the glass slide by
sugars. However, in a previous study of by Wong and co-workers, it was shown that the
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surface was saturated by the monosaccharide at concentrations above 100 µM.59 Since
most of our sugar concentrations were above 100 µM (except for 25 µM and 50 µM), we
assumed a full coverage of surface for the monosaccharide. There was no way of
measuring how much carbohydrate was attached on the surface of the slide for the
different sugar concentrations. An accurate measure of surface coverage of carbohydrates
on each spot is not available by the current techniques.
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Figure 26. Top: Binding curves for monosaccharide 5. Errors not shown.
Average deviation is ± 3.4 to that shown in Figure 24. Bottom: Binding curves for
trisaccharide 29. Erros not shown. Average deviation is ± 8 to that shown in Figure
24.
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To probe into this problem, we ran multiple binding studies of sugars
(disaccharide 15 was chosen for further studies) on the same slide instead of comparing
results from different slides. So, for each sugar concentration, 30 spots were generated
and tested with the same concentration of protein. Figure 27 below shows the scanned
results of the disaccharide investigated with six different concentrations of Con A. There
was a gradual increase in fluorescence intensity between disaccharide 18 and Con A as
the concentration of Con A increased.

50 µg/mL

30 µg/mL

10 µg/mL

20 µg/mL

5 µg/mL

2 µg/mL

Figure 27. Scanned image of binding interaction between disaccharide 18
and six concentrations of Con A.
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The plotted values showed that there was an increase in fluorescence as protein
concentration was increased (Figure 28). However, there was a slight decrease in binding
at higher sugar concentrations of 750 µM and 1000 µM with a protein concentration at 30
µg/mL. Generally these results were much better than those previously obtained (Figure
25). The average binding constant (KD) from these experiments for the disaccharide 15
was 58 nM (SD = 3.6 nM), which was not very different from 61 nM obtained
previously.
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Figure 28. Binding curve for disaccharide 18 and Con A printed at different
concentrations as shown. Errors not shown. Average deviation of ± 17 from that
shown in Figure 24.
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It was intriguing to us that the disaccharide showed better binding than the
trisaccharide. This might be attributed to the trisaccharide being bulkier than the
disaccharide and also due to the fact that the carbohydrate binding site of Con A is very
shallow. Since the disaccharide 18 was (1→2)-linked and the trisaccharide 29 was
(1→2)- and (1→3)-linked, we wanted to investigate if the (1→3)-linkage in the
trisaccharide was decreasing the binding effect with protein. Therefore, the (1→3)linked disaccharide 24 was synthesized, (For the synthesis of 24, see Part One of this
dissertation.) and its binding properties with Con A were determined by microarray
analysis (Figure 29).

Figure 29. (1→3)-Linked thiol-terminated disaccharide 24.

The result was that the (1→3)-linked disaccharide 24 showed less binding with
protein (KD = 68 nM) than the (1→2)-linked disaccharide 18 (58 nM). This shows the
importance of the point of connection between sugars (i.e., the sugar linkages). The
(1→2)-linkage for the disaccharide construction showed enhanced binding over that of a
(1→3)-linkage. The 2-position on mannose is axial, while the 3-position is equatorial;
therefore, the orientations of the disaccharides 15 and 24 are very different (Figure 30).
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Figure 30. Three-dimensional models of disaccharides; top: (1→2)-linked
disaccharide 15; bottom: (1→3)-linked disaccharide 24. (Structures were calculated
using Chem3D Pro version 12.0.2.1076).

The 3-OH and 4-OH required for binding with Con A are well exposed in both
the reducing and non-reducing sugar units of the (1→2)-linked disaccharide 15 which
might have led to multivalent binding. Contrarily, only the 3-OH and 4-OH of the nonreducing sugar unit of the (1→3)-linked disaccharide 24 is exposed for binding with Con
A. It is noteworthy that the (1→3)-linked disaccharide 24 also showed better binding
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with Con A than the trisaccharide 29. It has been shown before that when lectins bind
disaccharides, the non-reducing residue occupies the carbohydrate binding site.43 Since
the trisaccharide 29 is more sterically hindered than the disaccharide, it is therefore
reasonable that both the (1→2)-linked disaccharide 18 and the (1→3)-linked disaccharide
24 showed better binding to Con A. Figure 31 shows the scanned image of the binding
experiment between disaccharide 24 and Con A at 30 µg/mL.

Figure 31. Scanned image of binding between (1→3)-linked disaccharide 24
and 30 µg/mL of Con A.

The binding was much lower at sugar concentrations below 150 µM as evident in
the scanned image (Figure 31). However, from a sugar concentration of 150 µM, there
was a linear increase in the binding with Con A as the sugar concentration increased. The
highest binding was observed at a sugar concentration of 1000 µM and a Con A
concentration of 50 µg/mL as expected. The binding between disaccharide 24 and Con A
were quite similar at high sugar concentration of 750 µM and 1000 µM when Con A was
used at concentrations of 20 and 30 ug/mL.

141

3. Conclusions and future work
We successfully used microarray techniques to immobilize four synthesized thiolterminated derivatives on epoxide-functionalized glass slides. Reduction of background
signal from non-specific binding between protein and glass slide was the most
challenging step in the microarray analysis. Using ethanolamine buffer proved to be the
best block solution. The sugars used included monosaccharide 5, (1→2)-linked
disaccharide 18, (1→3)-linked disaccharide 24 and trisaccharide 29. Glycan arrays were
probed with Con A at six different concentrations (2, 5, 10, 20, 30 and 50 µg/mL). The
disaccharides 18 and 24 showed better binding with Con A with dissociation constants of
58 nM and 68 nM, respectively. This was attributed to the availability of two binding
sites on the (1→2)-linked disaccharide 18 as opposed to only one binding site on the
(1→3)-linked disaccharide 24. The (1→2)-linkage is necessary for increased binding
with Con A. Coverage of the surface by sugars has a direct effect on the binding with
Con A. However, the current technique does not give a measure of how much sugar is
immobilized on each spot. Therefore, future work will include controlling the binding site
density of the ligand arrays using synthesized nodes for direct attachment onto glass
surfaces. These nodes will be synthesized to have one, two, and three branches that can
react with sugars (Figure 33). Higher multiplicities will be generated by linking base
nodes together with linkers of varying lengths.
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Figure 32. Chemical structures and symbolic representation of node
structures.
In addition, alkyne-derivatized galactosides are currently being synthesized in the Baker
Laboratory by Bo Meng and Andrew Moss (Figure 34). Glycan microarrays will be
constructed with these galactose derivatives and their binding properties with mannosebinding lectins (control) and galactose-binding protein (GBP) will be determined.
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Figure 33. Alkyne-derivatized galactosides.
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4. Experimental
4.1. Materials
Epoxide-derivatized glass slides (Nexterion slide E, SCHOTT North America),
Rhodamine labeled Conconavalin A (Vector Labs), thiol-terminated mannose derivatives
(all synthesized as reported in part one); all other standard chemicals were purchased
from commercial suppliers and used as received. Glass slides were stored in a desiccator
to keep them dry.
4.2. Methods
4.2.1. Microarray fabrication
Printing sugar solutions were made up of sugar (1 mg/mL stock solutions in H2O), PBST
(300 mM phosphate-buffered saline and 0.05% Tween-20) of pH 8.9 and TCEP (5 mM
stock solution in H2O). The final TCEP concentration in each prepared sugar solution
was 2 mM. Eleven different concentrations (1, 2.5, 5, 10, 20, 30, 40, 50, 60, 80 and 100
mM) of each sugar were prepared in a 96-well plate. A control of 0 µg/mL of sugar was
also included. Using the standard robotic pin printer (Virtek ChipwriterTM Professional
Arrayer, Figure 20), the different solutions of sugars were printed on epoxidefunctionalized glass slides. Six identical supergrids were printed; each super grid had 3
grids, and each grid was printed in a 12 × 10 pattern. After an overnight incubation at
room temperature under 60% humidity, the slide surface was divided by drawing with
permanent-ink marker to avoid contamination during protein incubation. Slides were
washed by submerging them in petri dishes filled with wash buffer (PBS, pH 7.4
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containing 0.05% Tween-20) and gently shaking on a waver for 30 min. To block
unreacted epoxides, slides were submerged in petri dishes filled with a block solution (50
mM ethanolamine in 100 mM borate, pH 9.2) and gently shaken for 1 h on a waver. After
blocking, the slides were washed three times by immersing them in centrifuge tubes filled
with PBS buffer (pH 7.4) and dried by gentle purging with N2 air. Slides were
immediately used for incubation with protein.

4.2.2 Binding assay
Rhodamine-labeled Con A (5 mg/mL) was diluted in phosphate-BSA buffer (Con A
buffer: 50 mM, pH 6.5; 1 mM CaCl2, 1mM MnCl2, 0.9% NaCl (w/v), 1% BSA (w/v),
0.05% Tween-20). Six different concentrations of Con A were obtained: 2, 5, 10, 20, 30
and 50 µg/mL. An incubation chamber was fabricated by placing a damp, warm paper
towel in a covered plastic box. For incubations, 40–50 µL of protein solution was applied
to each supergrid and slides were placed in the incubation chamber and placed on the
shaker for 1 h at room temperature. After incubation, slides were washed three times in
petri dishes filled with incubation buffer (Con A buffer), three times with PBST buffer
(0.05% Tween-20), three times with distilled water, and then dried by gentle purging with
N2 air to ensure complete dryness. Each wash was approximately 5 min. The dried plates
were scanned immediately to obtain results.
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4.2.3. Data analysis
Fluorescence intensities of microspots were quantified, and the data was extracted by
using a microarray scanner (GenePix® 4000B, Axon Instruments). The images were read
using a 532 nm wavelength laser with the array reader. The local background was
subtracted from the signal at each spot. The spots with obvious defects, no detectable
signal or fluorescence lower than the background or higher were removed from the
analysis. The medians of ratios from replicate spots were averaged in the same array.
To determine the KD,surf value, the data was plotted using SigmaPlot version 11.0.
Two equations were used for best-fit curves where applicable: the ligand and the
sigmoidal binding equations. Ligand binding was applied for most binding curves. The
advantage to using ligand-fit binding equations was that the KD values were automatically
calculated by the SigmaPlot program. In order to calculate the binding constants, curves
were analyzed as Langmuir isotherms assuming equilibrium was reached during
incubation. The following equation was used to calculate the binding constants as
previously reported by Wong and co-workers. The calculated values matched those
generated by SigmaPlot according to the following equation:
KD,surf = [P] (Fmax – F)
F
Where, [P] = concentration of protein,
Fmax = maximum fluorescence intensity at protein concentration, a value that is
generated by SigmaPlot, and
F = Fluorescence intensity
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1

H NMR spectrum (300 MHz, CDCl3) of α-anomer of 1,2,3,4,6-Penta-O-acetyl-D-mannopyranose (2).
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13

C NMR spectrum (75 MHz, CDCl3) of α-anomer of 1,2,3,4,6-Penta-O-acetyl-D-mannopyranose (2).
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1

H NMR spectrum (300 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (3).
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13

C NMR spectrum (75 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (3).
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1

H NMR spectrum (300 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (4).
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13

C NMR spectrum (75 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (4).
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gHMBC NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (4).
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gCOSY NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (4).
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gHSQC NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (4).
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1

H NMR spectrum (300 MHz, CDCl3) of 3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranoside (5).
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13

C NMR spectrum (75 MHz, CDCl3) of 3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranoside (5).
168

1

H NMR spectrum (300 MHz, CD3OD) of allyl α-D-mannopyranoside (6).

169

13

C NMR spectrum (75 MHz, CD3OD) of allyl α-D-mannopyranoside (6).

170

gHSQC NMR spectrum (500 MHz, CD3OD) of allyl α-D-mannopyranoside (6).

171

1

H NMR spectrum (300 MHz, CDCl3) of allyl 4,6-O-benzylidene-α-D-mannopyranoside (7).
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13

C NMR spectrum (75 MHz, CDCl3) of allyl 4,6-O-benzylidene-α-D-mannopyranoside (7).
173

1

H NMR spectrum (300 MHz, CDCl3) of allyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (8).
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13

C NMR spectrum (75 MHz, CDCl3) of allyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (8).
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gCOSY NMR spectrum (300 MHz, CDCl3) of Allyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (8).

176

gHSQC NMR spectrum (300 MHz, CDCl3) of Allyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (8).
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1

H NMR spectrum (300 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 4,6-O-benzylidene-3-O-(4methoxybenzyl)-α-D-mannopyranoside (13).
178

13

C NMR spectrum (75 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 4,6-O-benzylidene-3-O-(4methoxybenzyl)-α-D-mannopyranoside (13).
179

1

H NMR spectrum (300 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl- (1→2)- 4,6-O-benzylidene-α-Dmannopyranoside (14).
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13

C NMR spectrum (75 MHz, CDCl3) of a allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl- (1→2)- 4,6-O-benzylidene-α-Dmannopyranoside (14).
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H NMR spectrum (300 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 3-O-acetyl-4,6-O-benzylidene-α-Dmannopyranoside (13).
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C NMR spectrum (75 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 3-O-acetyl-4,6-O-benzylidene-α-Dmannopyranoside (15).
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gHSQC NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 3-O-acetyl-4,6-Obenzylidene-α-D-mannopyranoside (15).
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gHMBC NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 3-O-acetyl-4,6-Obenzylidene-α-D-mannopyranoside (15).

185

gCOSY NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 3-O-acetyl-4,6-Obenzylidene-α-D-mannopyranoside (15).
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H NMR spectrum (300 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 3-Oacetyl-4,6-O-benzylidene α-D-mannopyranoside (16).
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C NMR spectrum (75 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)- 3-Oacetyl-4,6-O-benzylidene α-D-mannopyranoside (16).
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gCOSY NMR spectrum (300 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)3-O-acetyl-4,6-O-benzylidene α-D-mannopyranoside (16).
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H NMR spectrum (300 MHz, CD3OD) of 3-[(2-sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-α-D-mannopyranoside
(18).
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C NMR spectrum (75 MHz, CD3OD) of 3-[(2-sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-α-D-mannopyranoside
(18).
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H NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-4,6-O-benzylidene α-Dmannopyranoside (19).
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C NMR spectrum (125 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-4,6-O-benzylidene α-Dmannopyranoside (19).
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H NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-2-O-acetyl-4,6-O-benzylidene α-Dmannopyranoside (20).
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C NMR spectrum (125 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-2-O-acetyl-4,6-O-benzylidene α-Dmannopyranoside (20).
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gHSQC NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-2-O-acetyl-4,6-O-benzylidene
α-D-mannopyranoside (20).
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gCOSY NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-2-O-acetyl-4,6-O-benzylidene
α-D-mannopyranoside (20).
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gHMBC NMR spectrum (500 MHz, CDCl3) of Allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-2-O-acetyl-4,6-Obenzylidene α-D-mannopyranoside (20).
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H NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)- 2-Oacetyl-4,6-O-benzylidene-α-D-mannopyranoside (21).
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C NMR spectrum (125 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)- 2O-acetyl-4,6-O-benzylidene-α-D-mannopyranoside (21).
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gHSQC NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)2-O-acetyl-4,6-O-benzylidene-α-D-mannopyranoside (21).
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gHMQC NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→3)- 2-O-acetyl-4,6-O-benzylidene-α-D-mannopyranoside (21).
202

TOCSY NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→3)- 2-O-acetyl-4,6-O-benzylidene-α-D-mannopyranoside (21).
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gHMBC NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→3)- 2-O-acetyl-4,6-O-benzylidene-α-D-mannopyranoside (21).
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H NMR spectrum (500 MHz, CDCl3) of S-[2-[(3-{[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→3)-2,4,6-tri-O-acetyl-α-Dmannopyranosyl]oxy]propyl)sulfanyl]ethyl] ethanethioate (23).
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C NMR spectrum (125 MHz, CDCl3) of S-[2-[(3-{[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→3)-2,4,6-tri-O-acetyl-α-Dmannopyranosyl]oxy]propyl)sulfanyl]ethyl] ethanethioate (23).
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H NMR spectrum (500 MHz, CD3OD) of 3-[(2-sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→3)-α-D-mannopyranoside
(24).
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C NMR spectrum (125 MHz, CD3OD) of 3-[(2-sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→3)-α-D-mannopyranoside
(24).
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gHSQC NMR spectrum (500 MHz, CD3OD) of 3-[(2-sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→3)-α-Dmannopyranoside (24).
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DEPT NMR spectrum (500 MHz, CD3OD) of 3-[(2-sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→3)-α-D-mannopyranoside
(24).
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H NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25).
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C NMR spectrum (125 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25).
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gCOSY NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25).

213

gHSQC NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25).
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gHMBC NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25).
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NOESY NMR spectrum (500 MHz, CDCl3) of allyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25).
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H NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (26).
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C NMR spectrum (125 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (25).
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gHSQC NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (26).
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gHMBC NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→2)-[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (26).
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gCOSY NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (26).
221

NOESY NMR spectrum (500 MHz, CDCl3) of 3-[(2-sulfanylethyl)sulfanyl]propyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl(1→2)-[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (26).
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1

H NMR spectrum (500 MHz, CDCl3) of S-[2-[(3-[[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-di-O-acetyl-α-D-mannopyranosyl]oxy]propyl)sulfanyl]ethyl] ethanethioate (28).
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C NMR spectrum (125 MHz, CDCl3) of S-[2-[(3-[[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetyl-α-Dmannopyranosyl-(1→3)]-4,6-di-O-acetyl-α-D-mannopyranosyl]oxy]propyl)sulfanyl]ethyl] ethanethioate (26).
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gHMBC NMR spectrum (500 MHz, CDCl3) of S-[2-[(3-[[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-di-O-acetyl-α-D-mannopyranosyl]oxy]propyl)sulfanyl]ethyl] ethanethioate (28).
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gCOSY NMR spectrum (500 MHz, CDCl3) of S-[2-[(3-[[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-di-O-acetyl-α-D-mannopyranosyl]oxy]propyl)sulfanyl]ethyl] ethanethioate (28).
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gHSQC NMR spectrum (500 MHz, CDCl3) of S-[2-[(3-[[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-di-O-acetyl-α-D-mannopyranosyl]oxy]propyl)sulfanyl]ethyl] ethanethioate (28).
227

TOCSY NMR spectrum (500 MHz, CDCl3) of S-[2-[(3-[[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-di-O-acetyl-α-D-mannopyranosyl]oxy]propyl)sulfanyl]ethyl] ethanethioate (28).
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H NMR spectrum (500 MHz, CD3OD) of 3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-[α-Dmannopyranosyl-(1→3)]-α-D-mannopyranoside (29).
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C NMR spectrum (125 MHz, CD3OD) of 3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-[α-Dmannopyranosyl-(1→3)]-α-D-mannopyranoside (29).
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gHSQC NMR spectrum (500 MHz, CD3OD) of 3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-[α-Dmannopyranosyl-(1→3)]-α-D-mannopyranoside (29).
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gHMBC NMR spectrum (500 MHz, CD3OD) of 3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-[α-Dmannopyranosyl-(1→3)]-α-D-mannopyranoside (29).
232

gCOSY NMR spectrum (500 MHz, CD3OD) of 3-[(2-Sulfanylethyl)sulfanyl]propyl α-D-mannopyranosyl-(1→2)-[α-Dmannopyranosyl-(1→3)]-α-D-mannopyranoside (29).
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H NMR spectrum (300 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (31).
234

13

C NMR spectrum (75 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (31).
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H NMR spectrum (300 MHz, CD3OD) of propargyl α-D-mannopyranoside (30).
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C NMR spectrum (75 MHz, CD3OD) of propargyl α-D-mannopyranoside (30).
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H NMR spectrum (300 MHz, CDCl3) of propargyl 4,6-O-benzylidene-α-D-mannopyranoside (32).
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C NMR spectrum (75 MHz, CDCl3) of propargyl 4,6-O-benzylidene-α-D-mannopyranoside (32).
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H NMR spectrum (300 MHz, CDCl3) of propargyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (33).
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C NMR spectrum (75 MHz, CDCl3) of propargyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (33).
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gHSQC NMR spectrum (500 MHz, CDCl3) of propargyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside
(33).
242

gCOSY NMR spectrum (500 MHz, CDCl3) of propargyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside
(33).
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gHMBC NMR spectrum (500 MHz, CDCl3) of propargyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside
(33).
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H NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-4,6-O-benzylidene-α-Dmannopyranoside (35).
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C NMR spectrum (125 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-4,6-O-benzylidene-αD-mannopyranoside (35).
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gCOSY NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-4,6-Obenzylidene-α-D-mannopyranoside (35).
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gHSQC NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-4,6-Obenzylidene-α-D-mannopyranoside (35).
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gHMBC NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-4,6-Obenzylidene-α-D-mannopyranoside (35).
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gNOESY NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-4,6-Obenzylidene-α-D-mannopyranoside (35).
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H NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-3-O-acetyl-4,6-Obenzylidene-α-D-mannopyranoside (36).
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C NMR spectrum (125 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-3-O-acetyl-4,6-Obenzylidene-α-D-mannopyranoside (36).
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gHSQC NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-3-O-acetyl-4,6-Obenzylidene-α-D-mannopyranoside (36)
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C NMR spectrum (75 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-(1→2)-3,4,6-tri-O-acetyl-α-Dmannopyranoside (37).
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H NMR spectrum (500 MHz, CDCl3) of propargyl α-D-mannopyranosyl-(1→2)-α-D-mannopyranoside (38).
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C NMR spectrum (125 MHz, CDCl3) of propargyl α-D-mannopyranosyl-(1→2)-α-D-mannopyranoside (38).
256

1

H NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetylα-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (39).
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C NMR spectrum (125 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetylα-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (39).
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gHSQC NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (39).
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gCOSY NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (39).
260

gHMBC NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (39).
261

NOESY NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (39).
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H NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetylα-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
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C NMR spectrum (125 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-O-acetylα-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
264

gHSQC NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
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gCOSY NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
266

NOESY NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
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gHMBC NMR spectrum (500 MHz, CDCl3) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)-[2,3,4,6-tetra-Oacetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
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HSQCTOCSY NMR spectrum (500 MHz, CDCl3, 24 ms) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
269

HSQCTOCSY NMR spectrum (500 MHz, CDCl3, 50 ms) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
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HSQCTOCSY NMR spectrum (500 MHz, CDCl3, 80 ms) of propargyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→2)[2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)]-4,6-O-benzylidene-α-D-mannopyranoside (41).
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H NMR spectrum (500 MHz, CD3OD) of propargyl α-D-mannopyranosyl-(1→2)-[α-D-mannopyranosyl-(1→3)]-α-Dmannopyranoside (42).
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C NMR spectrum (125 MHz, CD3OD) of propargyl α-D-mannopyranosyl-(1→2)-[α-D-mannopyranosyl-(1→3)]-α-Dmannopyranoside (42).
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gHSQC NMR spectrum (500 MHz, CD3OD) of propargyl α-D-mannopyranosyl-(1→2)-[α-D-mannopyranosyl-(1→3)]-α-Dmannopyranoside (42).
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H NMR spectrum (300 MHz, CDCl3) of 2-[2-(benzyloxy)ethoxy]ethanol (45).
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C NMR spectrum (75 MHz, CDCl3) of 2-[2-(benzyloxy)ethoxy]ethanol (45).
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H NMR spectrum (300 MHz, CDCl3) of 2-[2-(benzyloxy)ethoxy]ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (46).
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C NMR spectrum (75 MHz, CDCl3) of 2-[2-(benzyloxy)ethoxy]ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (46).
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gHSQC NMR spectrum (300 MHz, CDCl3) of 2-[2-(benzyloxy)ethoxy]ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (46).
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gHMBC NMR spectrum (300 MHz, CDCl3) of 2-[2-(benzyloxy)ethoxy]ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (46).
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f1 (ppm)

gCOSY NMR spectrum (300 MHz, CDCl3) of 2-[2-(benzyloxy)ethoxy]ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (46).
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1

H NMR spectrum (300 MHz, CDCl3) of 2-(2-hydroxyethoxy)ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (47).
282

13

C NMR spectrum (75 MHz, CDCl3) of 2-(2-hydroxyethoxy)ethyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (47).
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1

H NMR spectrum (300 MHz, CDCl3) of 2-[2-[(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)oxy]ethoxy]ethyl 2,3,4,6-tetra-Oacetyl-(1→1)-α-D-mannopyranoside (44).
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13

C NMR spectrum (75 MHz, CDCl3) of 2-[2-[(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)oxy]ethoxy]ethyl 2,3,4,6-tetra-Oacetyl-(1→1)-α-D-mannopyranoside (44).
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gCOSY NMR spectrum (300 MHz, CDCl3) of 2-[2-[(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)oxy]ethoxy]ethyl 2,3,4,6-tetraO-acetyl-(1→1)-α-D-mannopyranoside (44).
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1

H NMR spectrum (300 MHz, CDCl3) of 2-[2-[(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)oxy]ethoxy]ethyl 2,3,4,6-tetra-Oacetyl-(1→1)-α-D-mannopyranoside (44).
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1

H NMR spectrum (300 MHz, CD3OD) of 2-[2-(α-D-mannopyranosyloxy)ethoxy]ethyl-(1→1)-α-D-mannopyranoside (48).
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13

C NMR spectrum (300 MHz, CD3OD) of 2-[2-(α-D-mannopyranosyloxy)ethoxy]ethyl-(1→1)-α-D-mannopyranoside (48).
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DEPT NMR spectrum (75 MHz, CD3OD) of 2-[2-(α-D-mannopyranosyloxy)ethoxy]ethyl-(1→1)-α-D-mannopyranoside (49).
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1

H NMR spectrum (300 MHz, CDCl3) of allyl 2-O-acetyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside
(9).
291

gCOSY NMR spectrum (300 MHz, CDCl3) of allyl 2-O-acetyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-Dmannopyranoside (9).
292

1

H NMR spectrum (300 MHz, CDCl3) of allyl 2-O-benzyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside
(10).
293

13

C NMR spectrum (75 MHz, CDCl3) of allyl 2-O-benzyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside
(10).
294

DEPT NMR spectrum (75 MHz, CDCl3) of allyl 2-O-benzyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside
(10).
295

gCOSY NMR spectrum (300 MHz, CDCl3) of allyl 2-O-benzyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-Dmannopyranoside (10).
296

gHSQC NMR spectrum (300 MHz, CDCl3) of allyl 2-O-benzyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-Dmannopyranoside (10).
297

gHMBC NMR spectrum (300 MHz, CDCl3) of allyl 2-O-benzyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-Dmannopyranoside (10).
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